Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2022 Nov 18;16(11):e0010339. doi: 10.1371/journal.pntd.0010339

Mechanistic models of Rift Valley fever virus transmission: A systematic review

Hélène Cecilia 1,¤,*,#, Alex Drouin 2,3,#, Raphaëlle Métras 4,5, Thomas Balenghien 2,6,7, Benoit Durand 3,*, Véronique Chevalier 2,8,9, Pauline Ezanno 1
Editor: Michael J Turell10
PMCID: PMC9718419  PMID: 36399500

Abstract

Rift Valley fever (RVF) is a zoonotic arbovirosis which has been reported across Africa including the northernmost edge, South West Indian Ocean islands, and the Arabian Peninsula. The virus is responsible for high abortion rates and mortality in young ruminants, with economic impacts in affected countries. To date, RVF epidemiological mechanisms are not fully understood, due to the multiplicity of implicated vertebrate hosts, vectors, and ecosystems. In this context, mathematical models are useful tools to develop our understanding of complex systems, and mechanistic models are particularly suited to data-scarce settings. Here, we performed a systematic review of mechanistic models studying RVF, to explore their diversity and their contribution to the understanding of this disease epidemiology. Researching Pubmed and Scopus databases (October 2021), we eventually selected 48 papers, presenting overall 49 different models with numerical application to RVF. We categorized models as theoretical, applied, or grey, depending on whether they represented a specific geographical context or not, and whether they relied on an extensive use of data. We discussed their contributions to the understanding of RVF epidemiology, and highlighted that theoretical and applied models are used differently yet meet common objectives. Through the examination of model features, we identified research questions left unexplored across scales, such as the role of animal mobility, as well as the relative contributions of host and vector species to transmission. Importantly, we noted a substantial lack of justification when choosing a functional form for the force of infection. Overall, we showed a great diversity in RVF models, leading to important progress in our comprehension of epidemiological mechanisms. To go further, data gaps must be filled, and modelers need to improve their code accessibility.

Author summary

Rift Valley fever (RVF) affects humans and livestock across Africa, South West Indian Ocean islands, and the Arabian Peninsula. This disease is one of the World Health Organization priorities and is caused by a virus which is transmitted by mosquitoes (mainly of Aedes and Culex spp. genera), but also by direct contact from livestock to humans. Mathematical models have been used in the last 20 years to disentangle RVF virus transmission dynamics. These models can further improve our understanding of processes driving outbreaks, test the efficiency of control strategies, or even anticipate possible emergence. Provided with detailed datasets, models can tailor their conclusions to specific geographical contexts and aid in decision-making in the field. This review provides a general overview of mathematical models developed to study RVF virus transmission dynamics. We describe their main results and methodological choices, and identify hurdles to be lifted. To offer innovative animal and public health value, we recommend that future models focus on the relative contribution of host and vector species to transmission, and the role of animal mobility.

Introduction

Rift Valley fever (RVF) is a viral, vector-borne, zoonotic disease, first identified in Kenya in 1930 [1]. It has since then been reported across the African continent, in the South West Indian Ocean islands, and in the Arabian Peninsula. Transmission of Rift Valley fever virus (RVFV) mainly involves Aedes and Culex spp. mosquitoes [2], some of which are present in Europe and North America [310], but other genera may also be potential vectors [1114]. In livestock, abortion storms and death can strongly impact the local economy [15,16]. Human infections arise mostly following contact with tissues of infected animals but is also vector-mediated. The clinical spectrum in humans is broad, with a minority of deadly cases [17,18].

About 100 years after its first description, RVF outbreaks are still difficult to anticipate and contain, and the drivers of RVF endemicity are not clearly understood. The multiplicity of vertebrate host and mosquito species involved, the diversity of affected ecosystems, each with their own environmental dynamics, as well as the impact of human activities, make this complex system hard to disentangle [19]. The limited use of available vaccines [20], coupled with the overall social vulnerability of affected regions [21,22], are also major obstacles. The pastoralist tradition, which constitutes the main production system in African drylands [23], can induce delayed access to health care and hinder the traceability of animal mobility. This, in turn, impacts the quality and the availability of epidemiological data, which can be quite heterogeneous [2426]. As a result, it is often difficult to generalize local findings, unless a mechanistic understanding of epidemiological processes is acquired.

Mathematical models are useful to project epidemiological scenarios, including control strategies. This can be done at large scales (temporal [27], spatial [28], or demographic [28]). Powerful methods can now estimate the most likely drivers of observed outbreak patterns [29,30], or point out key processes needing further field or laboratory investigations [31]. Phenomenological models, be they mathematical or statistical, aim at extracting patterns and information from data, with no focus on underlying mechanisms responsible for such observed patterns [32]. By contrast, mechanistic (sometimes called dynamical) models explicitly include processes governing the system of interest [32]. Consequently, mechanistic models can adapt to data-scarce settings by exploring a complex system conceptually, in a hypothesis-driven fashion [33], e.g., to see what ranges of behavior can emerge from first principles, as is routinely done in ecology [34]. This flexibility gives rise to an interesting variability in the way epidemiological mechanistic models are designed and used, spanning a broad spectrum from highly theoretical to closely mimicking field situations [35].

Two existing reviews have focused on models developed to study RVF. The first one, by Métras et al. (2011) [36], was a narrative review presenting modeling tools used to measure or model the risk of RVF occurrence in animals. At that time, only three mechanistic models were available and included in the study. The second one, by Danzetta et al. (2016) [37], was a systematic review constrained to compartmental models which included 24 articles. The authors used RVF as a case study to present how the use of compartmental models can be helpful to investigate various aspects of vector-borne disease transmission. A complementary paper, by Reiner et al. (2013) [38], reviewed 40 years of mathematical models of mosquito-borne pathogen transmission, with a thorough and comprehensive reading grid. It did however only include three models on RVF.

To update the state-of-the-art on mechanistic models of RVFV transmission, we conducted a systematic review. Our main goal was to identify knowledge gaps left unaddressed by models, and therefore identify future research avenues. To achieve this, we categorized models on a spectrum from theoretical to applied (the middle-ground category being called ‘grey’) and explored these categories throughout the paper to identify what they have in common and how they differ. First, we explored their inheritance connections and assessed whether these categories inspired each other. We then detailed their contribution to the understanding of RVF epidemiology. Lastly, we described the diversity of methodological choices and assumptions made in these models. In particular, we dedicated a whole section to present the different functional forms used by models for the force of infection. We detailed the underlying assumptions on host-vector interactions that these functional forms imply, as we noticed a lack of justification regarding this choice in reviewed papers, even though host-vector interactions represent a key factor in RVFV transmission. In that regard, we therefore insist that key results presented in this review should be interpreted with this methodological choice in mind.

Material and methods

Search strategy

This review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [39,40]. The research was performed in Scopus and Pubmed databases on 12 October 2021. No restriction on publication date was considered. The following Boolean query was applied in both databases: (rift AND valley AND fever) AND (mathematical OR epidem* OR compartment* OR sir OR seir OR metapopulation OR deterministic OR stochastic OR mechanistic OR dynamic*) AND (model*).

This query was used in the “title, abstract, and keywords”, and “title and abstract” fields for Scopus and PubMed, respectively.

Inclusion and exclusion criteria

After removal of duplicates, studies were included in three steps: title screening, abstract screening, and full text reading. In the first and second steps, records were selected if they appeared to present a RVF model using a mechanistic approach for at least one part of the model. Exclusion criteria were: irrelevant topic, reviews, case reports, serological studies, and statistical studies. Records selected in the first and second steps went to a full text screening of the corresponding report, using a combination of the first set of exclusion criteria along with the following additional ones: non-mechanistic models, models representing mosquitoes only, incomplete model description, and theoretical papers without any RVF numerical application. Discussion among authors occurred in case of doubt to reach a consensus on final inclusions.

Screening

We designed a reading grid (S1 Text), partially inspired by the one used in Reiner et al. (2013) [38], to collect information from the studies. The context of the study (e.g., location, presence of data), model components (e.g., host and vector species, infection states), and assumptions (e.g., vertical transmission in vectors), type of outputs (e.g., R0, parameter estimations, sensitivity analysis), and main results were all recorded. Two authors took charge of the systematic reading. To cross-validate the use of the grid, three studies were read by both authors and specific topics were regularly discussed to make sure a consensus was reached.

Model typology and inheritance connections

We defined three model categories: theoretical, applied, and grey models. Theoretical models do not use any data and are not intended to represent any specific geographical location. Applied models represent a specific geographical context and use relevant data to tailor model development to their case study or to validate model outputs. Such data can be of several types, as environmental or demographic data, and not necessarily epidemiological in the sense of seroprevalence or case reports. Grey models are those which do not fit into these well-defined categories. In some cases, authors do not use data but demonstrate a strong will to adapt their models to a specific geographical or epidemiological context. In other cases, despite the use of data, the model developed is still very conceptual and lacks realism in its key features. In such cases, the model analysis rarely deepens the epidemiological understanding of the pathosystem. We recorded inheritance connections between studies: if a model stated being adapted from another model, we defined the latter as a parent model.

Results and discussion

Study selection

A total of 372 records were identified from the two databases. After removal of duplicates, 248 records were screened at the title level, 146 at the abstract level, and 69 reports were fully read. Twenty-one reports were excluded during full-text reading: three were excluded due to incomplete model description [4143], three modeled mosquito population only [4446], ten were not mechanistic models [4756], three were review papers [5759] and two were theoretical without application to RVF [60,61]. Eventually, 49 studies were selected for the present review (Fig 1). Among those, 26 were not present in the review by Danzetta et al. (2016) [37].

Fig 1. PRISMA flow diagram representing the selection process.

Fig 1

Record: title and/or abstract of a report indexed in a database. Report: document supplying information about a study. Study: An experiment, corresponding here to models [39]. * One report included two studies.

Model typology and inheritance connections

We identified 18 applied models (37%), 18 theoretical models (37%), and 13 grey models (26%, Table 1). Twenty-one models (43%) had a parent model within the list of presently reviewed studies, for a total of twenty-seven models in the inspirational network (Fig 2). In 15 cases (71%), a model and its parent shared at least one author. In 14 cases, a models and its parent belonged to the same category (6 applied, 1 grey, 7 theoretical). The model by Gaff et al. (2007) [62] is a clear example of a model laying the groundwork for future model developments. It was first modified to explore several control strategies in Gaff et al. (2011) [63] (theoretical). Adongo et al. (2013) [64] (theoretical) then elaborated on Gaff et al. (2011) [63] to explore sophisticated vaccination schemes. Besides, Gaff et al. (2007) [62] model was spatialized in Niu et al. (2012) [65] (theoretical). In other cases, theoretical and grey studies provided a basis for the construction of more applied models in further work. One grey model [66] was the parent of an applied model [67]. In four cases, a theoretical model ([62] twice, [68], [69]) was a parent of a grey model ([70], [71], [72], and [66] respectively). Lastly, Gaff et al. (2007) [62], a theoretical model, was the parent of two applied models [73,74].

Table 1. Main characteristics of mechanistic models on Rift Valley fever virus transmission included in the review.

Study Model category Primary objective Main output Deterministic or stochastic? Geographical zone Scale Number vertebrate hosts taxa Taxa Host infection states Number vector taxa Taxa Vector infection states FOI Compartmental or ABM? Code access
Beechler et al. (2015) [67] Applied Understand Scenario comparison Deterministic South Africa Local 1 Buffalo SIR 1 Aedes (assumed) SEI Hybrid1 Compartmental No
Bicout and Sabatier (2004) [85] Applied Understand Scenario comparison Deterministic with at least one stochastic process Senegal Local 1 Livestock IR (other states not described) 2 Aedes, Culex Not explicit FR Compartmental No
Scoglio et al. (2016) [86] Applied Understand Scenario comparison Stochastic United States of America Sub-national 1 Cattle SEIR 0 NA ABM Yes
Sekamatte et al. (2019) [87] Applied Understand Scenario comparison Stochastic Uganda Sub-national 1 Cattle SEIR 0 NA ABM No
Leedale et al. (2016) [82] Applied Understand Risk map Deterministic Kenya, Tanzania International 1 Livestock SEIR 2 Aedes, Culex SEI FR Compartmental No
Cecilia et al. (2020) [88] Applied Understand Risk map Deterministic Senegal Sub-national 2 Cattle, Small ruminants SEIR 2 Aedes, Culex SEI FR Compartmental Yes
Xue et al. (2013) [76] Applied Understand Risk map Deterministic with at least one stochastic process United States of America Sub-national 2 Cattle, Human SEIR 2 Aedes, Culex SEI FI Compartmental No
Xue et al. (2012) [74] Applied Understand Parameter estimation Deterministic South Africa Sub-national 2 Sheep, Human SEIR 2 Aedes, Culex SEI FI Compartmental No
Nicolas et al. (2014) [90] Applied Understand Parameter estimation Deterministic Madagascar Sub-national 1 Cattle SEIR 1 Not precised SEI FR Compartmental No (upon request)
Métras et al. (2017) [78] Applied Understand Parameter estimation Deterministic Mayotte Sub-national 1 Livestock SEIR 0 NA Compartmental No
Métras et al. (2020) [77] Applied Understand Parameter estimation Deterministic Mayotte Sub-national 2 Livestock, Human SEIRVsVp 0 NA Compartmental Yes
Tennant et al. (2021) [80] Applied Understand Parameter estimation Deterministic Comoros archipelago International 1 Livestock SEIR 0 NA Compartmental Yes
Durand et al. (2020) [91] Applied Understand Parameter estimation Deterministic with at least one stochastic process Senegal Local 2 Cattle, Small ruminants SIR 2 Aedes, Culex SEI FR Compartmental No
Barker et al. (2013) [73] Applied Anticipate Risk map Deterministic United States of America Sub-national 2 Cattle, Birds SEIR 2 Aedes, Culex SEI FI Compartmental No
Fischer et al. (2013) [92] Applied Anticipate Risk map Deterministic Netherlands National 2 Cattle, Small ruminants SEIR 2 Aedes, Culex SEI FR Compartmental No
Taylor et al. (2016) [81] Applied Anticipate Risk map Deterministic East African Community International 1 Livestock R (other states not described) 2 Aedes, Culex Not specified FR Compartmental No
EFSA AHAW Panel et al. (2020 –Model 1) [79] Applied Control Scenario comparison Stochastic Mayotte Sub-national 1 Livestock SEIRV 1 Culex SEI NA Compartmental No
EFSA AHAW Panel et al. (2020 –Model 2) [79] Applied Control Risk map Stochastic Netherlands National 1 Livestock SIR 0 FR Compartmental No
Gao et al. (2013) [84] Grey Understand Scenario comparison Deterministic Sudan, Egypt International 1 Livestock SIR 1 Not precised SI MA Compartmental No
Manore and Beechler (2015) [66] Grey Understand Scenario comparison Deterministic South Africa Local 1 Buffalo SIR 1 Aedes SEI Hybrid1 Compartmental No
Xiao et al. (2015) [83] Grey Understand Scenario comparison Deterministic Sudan, Egypt International 1 Livestock SEIR 1 Culex SEI MA Compartmental No
Lo Iacono et al. (2018) [93] Grey Understand Scenario comparison Deterministic Kenya National 1 Livestock SEIR 2 Aedes, Culex SEI Hybrid3 Compartmental No
Sumaye et al. (2019) [94] Grey Understand Scenario comparison Deterministic Tanzania Sub-national 2 Cattle, Human SEIR 4 Aedes, Culex SI Hybrid1 Compartmental Yes
McMahon et al. (2014) [95] Grey Understand Scenario comparison Deterministic with at least one stochastic process East Africa International 3 Cattle, Wildlife, Human SEIRAV 2 Aedes, Culex SEI Hybrid2 Compartmental No
Gil et al. (2016) [96] Grey Understand Scenario comparison Both tested Egypt National 1 Livestock SIR 1 Culex SI MA Both tested No
Tuncer et al. (2016) [97] Grey Understand Parameter estimation Deterministic Kenya Sub-national 2 Livestock, Human SI-R for livestock only 1 Not precised SI MA* Compartmental No
Cavalerie et al. (2015) [71] Grey Understand Parameter estimation Stochastic Mayotte Sub-national 1 Livestock SEIR 1 Mean from several species SEI FR Compartmental Yes
Mpeshe et al. (2014) [72] Grey Understand Sensitivity analysis Deterministic Tanzania Sub-national 2 Livestock, Human SEIR 2 Aedes, Culex SEI FI Compartmental No
Pedro et al. (2016) [98] Grey Understand Mathematical properties Stochastic East Africa, South Africa 1 Livestock SIR 1 Aedes SI Hybrid1 ABM No
Miron et al. (2016) [70] Grey Anticipate Sensitivity analysis Deterministic North America Local 2 Livestock, Human SEIR 1 Aedes SEI MA Compartmental No
Gachohi et al. (2016) [99] Grey Control Scenario comparison Deterministic Kenya Local 2 Cattle, Small ruminants SEIR 2 Aedes, Culex SEI FR Compartmental Yes
Niu et al. (2012) [65] Theoretical Understand Scenario comparison Deterministic 1 Livestock SEIR 2 Aedes, Culex SEI FI Compartmental No
Chamchod et al. (2014) [100] Theoretical Understand Scenario comparison Deterministic 1 Livestock SIR 1 Not precised SI FR Compartmental No
Pedro (2018) [101] Theoretical Understand Scenario comparison Deterministic 1 Livestock SIR 1 Aedes SI FR Compartmental No
Wen et al. (2019) [102] Theoretical Understand Scenario comparison Deterministic 1 Livestock SEIR 1 Not precised SEI MA Compartmental No
Python Ndekou Tandong et al. (2020) [89] Theoretical Understand Scenario comparison Deterministic 1 Animals SEIR 2 Aedes, Culex SEI FI Mixed** No
Mpeshe (2021) [103] Theoretical Understand Scenario comparison Deterministic 1 Human SEIR 1 Not precised SEI FI Compartmental No
Xue and Scoglio (2015) [104] Theoretical Understand Scenario comparison Deterministic with at least one stochastic process 1 Livestock SEIR 1 Not precised SEI FR Compartmental No
Gaff et al. (2007) [62] Theoretical Understand Sensitivity analysis Deterministic 1 Livestock SEIR 2 Aedes, Culex SEI FI Compartmental No
Mpeshe et al. (2011) [68] Theoretical Understand Sensitivity analysis Deterministic 2 Livestock, Human SEIR 1 Not precised SEI FI Compartmental No
Chitnis et al. (2013) [69] Theoretical Understand Sensitivity analysis Deterministic 1 Cattle SIR 1 Aedes SEI Hybrid1 Compartmental No
Xue and Scoglio (2013) [105] Theoretical Understand Sensitivity analysis Deterministic 2 Livestock, Human SEIR 2 Aedes, Culex SEI FI Compartmental No
Pedro et al. (2016) [75] Theoretical Understand Sensitivity analysis Deterministic 1 Livestock SIRA 2 Aedes, Culex SEI Hybrid1 Compartmental No
Pedro et al. (2017) [106] Theoretical Understand Sensitivity analysis Deterministic 1 Livestock SIR 3 Aedes, Culex, Hyalomma ticks SE (Mosquitoes only) I Hybrid1 Compartmental No
Pedro et al. (2014) [107] Theoretical Understand Mathematical properties Deterministic 1 Livestock SIRA 2 Aedes, Culex SEI Hybrid1 Compartmental No
Gaff et al. (2011) [63] Theoretical Control Scenario comparison Deterministic 1 Cattle SEIRV 2 Aedes, Culex SEI FI Compartmental No
Adongo et al. (2013) [64] Theoretical Control Scenario comparison Deterministic 1 Livestock SEIR 2 Aedes, Culex SEI FI Compartmental No
Chamchod et al. (2016) [108] Theoretical Control Scenario comparison Deterministic 1 Livestock SIRV1V2 1 Not precised SI MA Compartmental No
Yang and Nie (2016) [109] Theoretical Control Scenario comparison Deterministic 1 Livestock SIR 1 Not precised SI MA Compartmental No

We chose not to assign a scale to theoretical models, as well as those with a vaguely defined geographical context. Note that computations covered timespans from 2 months to tens of years. Meaning of abbreviated infection states: susceptible (S), exposed (E), infected (I), recovered (R), asymptomatic (A), Vaccinated but still susceptible (Vs), Vaccinated and protected (Vp), Vaccinated (V), vaccinated by live vaccines (V1), vaccinated by killed vaccines (V2). FOI: force of infection (functional form). FR: reservoir frequency-dependent, FI: infectious frequency-dependent, MA: mass action (*: mass action with transmission rate dependent on pathogen load; immuno-epidemiological model), NA: not applicable (models with no explicit vector compartments); see section on Force of infection and Box 1 for details. ABM: agent-based model. All ABM models used individual animals as agents, except for Python Ndekou Tandong et al. (2020) [89] (**: agent-based modeling for animal mobility, with cities and trucks as agents exchanging animals, compartment model for transmission within cities.)

Fig 2. Inspirational network of models.

Fig 2

Nodes are labeled with the reference of the associated studies (year abbreviated), shaped by model category, and colored by the functional form of the force of infection (FR: reservoir frequency-dependent, FI: infectious frequency-dependent, MA: mass action, NA: not applicable (models with no explicit vector compartments); see section on Force of infection and Box 1 for details). An edge between two nodes represents a model declaring the other as its parent model, as defined in the main text. Twenty-two models are not shown in this plot as they did not declare a parent model within the list of presently reviewed studies.*[75]. ** [76].

Changes in model features can also give an overview of the continuity between a model and its parent. Métras et al. (2020) [77] added a human compartment to the model of Métras et al. (2017) [78] and ran the parameter estimation algorithm on a new outbreak dataset. One of the two models described in EFSA AHAW Panel et al. (2020)[79] then made a stochastic model based on Métras et al. (2017, 2020) [77,78]. Tennant et al. (2021) [80] transformed the single-patch model of Métras et al. (2017) in Mayotte into a metapopulation model for the Comoros archipelago. Taylor et al. (2016) [81] used the model by Leedale et al. (2016) [82] set in Kenya and Tanzania to explore a new research question, i.e., to anticipate the effect of climate change in East African Community. Xiao et al. (2015) [83] modified the model by Gao et al. (2013) [84] to include seasonality through time-varying parameters.

Contribution to the understanding of RVF epidemiology

Objective of the modeling study

To broadly describe the contribution of models to the study of RVF epidemiology, three main scientific objectives were identified (Table 1): exploring epidemiological mechanisms (‘understand’, n = 38), examining consequences of hypothetical outbreaks (‘anticipate’, n = 4), and assessing control strategies (‘control’, n = 7). In the present section, we focus on key features identified per objective.

The most common primary scientific objective of models was to understand epidemiological processes, in all model categories (from 72% of applied models to 79% of grey models, Table 1, Fig 3). Although in 11 cases, those models also aimed to anticipate or control outbreaks in a secondary part [62,77,78,80,8689,95,98,100]. In addition, in 30% of cases, model development in itself seemed to be a leading objective of the study. In such cases, contributing to RVF epidemiology was as important as contributing methodologically to RVF mechanistic modeling, by including for the first time a given compartment, parameter, or by developing a method to integrate data.

Fig 3. Association between the model category, the primary objective of the study, and the main type of output chosen to illustrate the results.

Fig 3

This figure excludes two models for which the main output consisted of a deep analysis of the mathematical properties of the system (Table 1).

An interesting trend is the evolution of the objectives of modeling papers over the years, which increasingly include the control and anticipation of RVF outbreaks (15/26 studies in 2016-present, 7/23 in 2004–2015). Research on RVF, through mathematical modeling and other methods, has deeply enhanced our understanding of underlying epidemiological mechanisms, which now allows models to focus more on operational aspects. However, some papers did not formulate a precise research question and consequently did not tailor their model to a specific set of hypotheses or scenarios to test. Theoretical models have helped to broadly explore the pathosystem behavior when dealing with a lot of uncertainty, but such papers often lack clarity. A difficulty for theoretical papers is to convey how mathematical analysis can be helpful to field practitioners down the line [110]. Regarding applied and grey models, their specificity often relied on the geographical application and the dataset they used, rather than on a focused research question.

Main outputs

The main output of a model, holding the key message of the studies, could pertain to one of four main categories (Table 1): i) parameter estimation (n = 8), ii) risk maps (n = 7), iii) comparison of scenarios, defined as a small set of simulations with specific parameters varied (or processes turned off) across a small set of values (n = 25), and iv) sensitivity analysis, where a large subset (if not all) of parameters are varied across a large set of values (e.g., using sampling design to generate them), usually to produce an index quantifying the impact of each parameter on selected model outputs (n = 7). In two additional cases, the main results relied on a deep analysis of the mathematical properties of the system (e.g., van Kampen system-size expansion [98], Lyapunov exponent, Poincaré map [107]). A given paper could have produced several of these outputs but we tried to identify, with an inevitable part of subjectivity, the one standing out as the main output.

The main model output varied according to the model category and their primary objective (Table 1, Fig 3). Scenario comparison was the only main output used by all model categories (Fig 3). Indeed, this type of analysis is flexible and can focus on a specific hypothesis and its impact on the system’s behavior. Risk maps were only produced as a main output by applied models, and was the most common output for models with the aim to anticipate (Fig 3). Sensitivity analyses were mostly used by theoretical models as a main output (5/7), and never as such by applied models (Fig 3, 3/10 by grey models). Parameter estimation was mostly performed by applied models (6/8), and not at all by theoretical models (Fig 3, 2/8 by grey models). By nature, sensitivity analyses and parameter estimation are primarily done to understand the system better. Here, we highlight that theoretical and applied models can use different tools to contribute to a common objective. In three cases, parameter estimations were used further in the same model to help anticipate [78] or control [77,80] outbreaks, as a secondary objective. Fifty-five percent of models provided an estimation of a type of reproduction number, e.g., the basic reproduction number R0, the effective reproduction number Re, the seasonal reproduction number Rst (phenomenological relationship estimated between environmental parameters and transmission rate), or the Floquet ratio RT (the expected number of cases caused by a primary case after one complete cycle of seasons [111]). Most of these reproduction numbers were obtained analytically (25/27). These estimates were highly variable and are therefore not reported here.

Key questions

Mechanistic models can help gauge the importance of hardly observable epidemiological processes, such as vertical transmission in vectors. This transmission route was included in around 50% of models, all having ‘understand’ as a main objective of the study. This seems representative of current knowledge on the importance of this process in the field. Indeed, evidence is limited regarding its potential role in the interepidemic maintenance of the virus [112]. Five models centered their research question on the quantification of this mechanism, in all categories (2 theoretical, 2 grey, 1 applied). Chitnis et al. (2013) [69] (theoretical) showed that while the vertical transmission rate does not impact R0, it can contribute significantly to inter-epidemic persistence. Pedro et al. (2016) [75] (theoretical) estimated a linear and significant effect of vertical transmission on R0 and vector eradication effort, although this effect became substantial only when vertical transmission rate was above 20% (percentage of infected mosquitoes’ progeny which are infected). Such a rate seems much higher than what has been observed experimentally [113,114]. Manore & Beechler (2015) [66] (grey) focused on inter-epidemic activity in Kruger National Park (South Africa) and estimated that realistic vertical transmission rates should be combined with the presence of alternate hosts to allow RVF persistence. Lo Iacono et al. (2018) [93] (grey) showed that vertical transmission of RVFV in Aedes spp. was not a prerequisite for RVF persistence over time in Kenya. Durand et al. (2020) [91] (applied) concluded that vertical transmission could not be ruled out but nomadic herd movements were sufficient to explain the enzootic circulation of RVFV in Senegal. The inconsistent conclusions from those models might indicate a spatially and temporally heterogeneous role of vertical transmission in RVFV maintenance. Moreover, most models have considered a uniform vertical transmission rate. However, it is more likely that the percentage of infected progeny may vary depending on individuals. For instance, it has been evidenced in Aedes dorsalis the possible existence of ’stabilized infections’ for the California encephalitis virus [115], i.e., a very small percent of mosquitoes are able to infect virtually 100% of their progeny, so that infection in mosquitoes is able to persist over several generations. Models could be used to explore this scenario, as the same mechanism has been suggested for RVFV [113].

The importance of animal movements in RVFV spread and persistence is another key question explored by included studies. Theoretical models show that local and distant spread of the virus are positively correlated to animal movement speed and flow size [83,89], but complex relationships exist in case of heterogeneous movements and livestock death rates across the network [105]. Spatial spread can also be limited by physical barriers to livestock migration [65]. The role of animal movements in RVFV spread is highlighted by applied models, especially with a low transmission probability [87] or in a low vectorial capacity [86] context. Métras et al. (2017) [78] suggested that import of infected livestock in 2007 was a major driver of RVF emergence in Mayotte in 2008–2010, and Gao et al. (2013) [84] that a transport of only a few infectious animals from Sudan to Egypt could be sufficient to start an outbreak. Across the Comoros archipelago, RVFV seems to be able to persist even in the absence of new introductions, with Grande Comore and Moheli more likely to sustain local transmission without new viral introductions [80].

Original research questions stood out from the rest. Beechler et al. (2015) [67] studied the impact of co-infections with the mycobacterium causing bovine tuberculosis (BTB). Their data highlighted that RVFV infection was twice as likely in BTB+ than BTB- individuals. Once this effect was incorporated in a model, an increase in BTB prevalence nonlinearly affected three RVF outbreak metrics: the outbreak size in both BTB-infected and BTB-free populations, the timing of the peak, and the outbreak duration. Pedro et al. (2017) [106] looked at the possible role of ticks as vectors in addition to mosquitoes. They concluded that if ticks were capable of carrying and transmitting RVFV, this would sensibly change the transmission dynamics. Specifically, the size of outbreaks was increased, with a higher peak, reached faster, and the outbreak duration was reduced, compared to a situation with only mosquito vectors. It should be noted, however, that there is currently no evidence of the ability of ticks to biologically transmit the virus [116]. By contrast, other species which have been experimentally demonstrated as competent, either as biological (such as sandflies [117,118]), or mechanical vector [119] have not been included so far in RVF models. Tuncer et al. (2016) [97] developed an immuno-epidemiological model in which pathogen load impacted transmission rate, and focused on the identifiability of parameters (i.e., the uniqueness of parameter values able to reproduce a given model trajectory) rather than the epidemiological impact of such a hypothesis.

A single model [81] has looked at the possible effect of climate change on RVF risk, in Eastern Africa. This likely does not reflect a lack of interest for this issue, but could rather indicate that mechanistic modeling is not the preferred method to study such trends, compared to phenomenological (i.e., statistical) models [120123]. In their review, Métras et al. (2011) [36] had highlighted the widespread use of phenomenological models to assess RVF risk across spatio-temporal scales. Phenomenological models can play a key role in selecting relevant processes to include or characterize suitable habitats, by highlighting significant correlations in complex datasets [124126]. Such phenomenological models can then be nested into mechanistic models for specific processes (e.g., temperature-dependency, density-dependency). Mechanistic and phenomenological approaches can be seen as complementary ways to build a comprehensive view of vector-borne and zoonotic pathosystems [127]. Still, how to prioritize research on livestock and human health in the context of climate change is up to debate [128,129].

Control measures

Currently, vaccination against RVFV is only available for livestock, using live attenuated virus or inactivated virus vaccines, with limitations in their use [130]. Ten models reflected on possible vaccination strategies (Table A in S1 Text), in all categories (3 applied, 5 theoretical, 2 grey). The main objectives of all of these studies were to ‘control’, except for Métras et al. (2020) [77] for which it was a secondary objective. Such strategies were shaped by parameters such as the time to build-up immunity, vaccine efficacy, coverage, and regimen (Table A in S1 Text). Most models confirmed quantitatively the intuitive need for vaccination to happen before outbreaks or quickly after the first cases are detected, to have a significant impact (Table A in S1 Text). EFSA AHAW Panel et al. (2020—Model 1), Gachohi et al. (2016) and Métras et al. (2020) [77,79—Model 1,99] incorporated constraints on the number of individuals vaccinated per day, so that a given coverage is reached at a realistic pace. Regarding the choice of hosts to vaccinate, Gachohi et al. (2016) [99] highlighted that while small ruminants needed a smaller coverage than cattle to achieve a given reduction in incidence, the vaccination of cattle provided the benefit of protecting both ruminant populations. This important role of cattle in RVFV transmission was due to a higher vector-to-host ratio and a larger body surface area, attracting more mosquitoes. Métras et al. (2020) [77] was the only model evaluating a possible human vaccination campaign. They estimated that, in the context of Mayotte island, vaccination of livestock was the most efficient strategy to limit human cases, compared to human vaccination. It required fewer doses than human vaccination to achieve a similar reduction in cases, assuming a highly immunogenic, single dose, and safe vaccine were available in both populations. This model took into account human exposure to livestock in their risk of infection. Adongo et al. (2013) [64] showed that optimal strategies differed depending on whether one prioritized the minimization of costs (doses) or of infections, with no clear take-home message for policy makers. Chamchod et al. (2016) [108] explored differences between the use of live and killed vaccines, and showed that due to the associated reversion of virulence, the use of live vaccines could render RVFV enzootic in situations where R0 is initially below one.

Vector control methods, using adulticides or larvicides, are expensive and difficult to implement, due to the diversity of potential vector species and of larval developmental sites to treat [17,20]. These mitigations methods have been tested in a few models, with ambiguous results. Miron et al. (2016) [70] concluded that reducing mosquito lifetime under 8.7 days would reduce R0 below one. In one study [63], both adulticides and larvicides were efficient to reduce the number of cases, when compared to no-intervention in a context of high virus transmission. In Mayotte, mosquito abundance had to be decreased by more than 40% to reduce RVF incidence and epidemic length, and an increased duration of epidemics was observed with lower levels of control [79—Model 1]. In the same model, vector control showed efficiency when coupled with culling strategy.

Few models considered movement restriction as a control method. A reduction of movements led to a decrease in disease spatial spread [86] and in incidence [95], and can help to eradicate the disease [89]. In Uganda, Sekamatte et al. (2019) [87] concluded that during periods of low mosquito abundance, movement restrictions led to a significant reduction in incidence. Movement restrictions had little impact in case of high vector abundance if used alone, and should therefore be combined with mosquito control. However, in some cases, mitigating measures could have unexpected consequences. In Comoros, scenarios of movement restriction between Grande Comore and other islands of the archipelago delayed the outbreak to a more suitable season, making it more severe overall [80]. By contrast, within-island control appeared to be more effective.

Testing and culling infected animals has been compared to other mitigations methods by three studies. This appeared to be one of the best strategies when conducted during 28 days after the detection of an outbreak in the theoretical model by Gaff et al. (2011) [63]. In the Netherlands, a RVFV-free area, a model concluded that stamping out in a 20 km radius around an outbreak could be the most effective strategy when comparing with scenarios of vaccination or other culling strategies [79—Model 2]. Nevertheless, in Mayotte, an effective strategy seemed hard to implement due to the high levels of animal testing and culling required [79—Model 1].

Overall, modeling studies often (6 applied, 6 theoretical, 3 grey) incorporate control-like scenarios, but the applicability of such simulations can be improved. Few models tried to assess RVF mitigation strategies in real endemic settings. Indeed, among six studies set in areas with history of RVFV circulation, only two had ‘prevent’ as a primary objective. Vaccination (n = 10) and vector control (n = 5) were the main strategies considered by models, although they currently present major on-field limitations [20]. In addition, simulated vector control scenarios are often simplistic, consisting of a variation of one parameter homogeneously, and only one model distinguished the use of larvicides and of adulticides [63]. Finally, only five models considered movement restrictions as a mitigation strategy, which has been highlighted as a key determinant of RVFV spread and persistence in some epidemiological contexts [91]. Future efforts should focus on incorporating field constraints into their scenarios, while keeping in mind the transboundary nature of RVFV transmission [131133].

Model features

Geographical context

Locations of applied and grey models are mapped in Fig 4A. The scale of applied and grey models varied from local to international (Fig 4B). The sub-national scale was the most prevalent in both applied (10/18) and grey models (4/13) (Fig 4B). Regarding zones with known presence of RVF, several countries reporting numerous outbreaks in the last 15 years [20] have had at least one specific model developed (Burundi, Comoros, Kenya, Madagascar, Rwanda, Senegal, South Africa, Sudan, Tanzania, and Uganda). Besides, the Netherlands and the USA, both RVF-free, were also used as case studies for several models.

Fig 4.

Fig 4

A—Geographical context and number of RVF models. Grey models are mapped but not counted in totals because they sometimes refer to a non-precise context (e.g., East Africa, North America, see B). Locations of grey models which are not also studied in applied models are shown in grey (Egypt, Sudan). The point north of Madagascar, accompanied by text, is centered on the Comoros archipelago. It stands for four models applied to Mayotte island and one model applied to the whole Comoros archipelago, including Mayotte. Map source: Natural Earth (https://www.naturalearthdata.com/). B—Scale of applied and grey models. Labels represent model locations, with one label per model, hence sometimes repeated locations. Labels are colored to help identify the scale (y-axis). East African Community = Burundi, Kenya, Rwanda, and Tanzania. Besides, all four models applied to Mayotte considered the whole island (374 sq. km), but those models are classified as sub-national. Sub-figures A and B are not restricted to spatial models (for those specifically, see Table B in S1 Text).

Spatial models, with at least two distinct locations, represented 45% (n = 22) of models (Table B in S1 Text). Among those, twelve were applied, five theoretical, and five grey models. All were discrete spatial models. Sixteen out of twenty-two (73%) spatial models incorporated connections between their spatial entities (Table B in S1 Text): vertebrate hosts moved in nine cases, vectors and hosts could move in three cases, and in four other cases, the connection was indirect, in the sense that the force of infection of one location was influenced by neighbors, taking into account distance, or prevalence. Three models were not spatialized but did include emigration and immigration of hosts (Table B in S1 Text).

It should be noted that regions with recurring virus circulation, such as Botswana, Mauritania, Mozambique, or Namibia [20] are still left out from the RVF modeling effort. Identifying the possible hurdles preventing model development in those regions is important. In addition, RVF being a transboundary animal disease, larger scale models are needed, able to gauge the role of animal movements in the transmission dynamics. Currently, international applied models do not incorporate connections between their spatial entities (Table B in S1 Text), probably due to a lack of data. A coordinated data collection effort is required across affected countries, focusing on both commercial and pastoral mobility, and making these data easily accessible to epidemiological research teams.

Data

Data were used in 25 out of 49 (51%) models. Here, we define data as any raw information, as opposed to a readily available parameter value extracted from another study. Several types of data were used (Table C in S1 Text): experimental (4/25), environmental (19/25), epidemiological (15/25), demographic (18/25), related to movements (6/25, Table B in S1 Text), and geographical (6/25). Most (23/25) models used more than one type of data, and sometimes had several distinct datasets per type (Table C in S1 Text). Among grey models, seven used data and six did not.

We identified a total of 102 datasets (Table C in S1 Text), corresponding to four datasets per model on average (102/25), ranging from two to ten. Only 44% of all datasets used by models incorporated a spatial dimension (measures in at least two distinct locations), and 45% a time dimension (measures for at least two different time points) (Table C in S1 Text). Regarding epidemiological datasets (n = 24), 25% were spatialized, and 58% were time-series (Table C in S1 Text). This is lower than environmental datasets (n = 28), which were 57% spatialized and 86% time-series (Table C in S1 Text). This supports conclusions made in recent reviews [24,25] which highlighted important gaps in RVF epidemiological data. Specifically, such gaps included the lack of fine-scale geographical metadata, preventing the study of within-country variation; the need for long-term studies in both endemic and non-endemic countries, to evaluate a possible increase in RVFV activity and exposure; and studies considering wildlife, livestock, and human concurrently, using standardized reporting and uniform case definitions [24,25]. Potential corrective measures would depend on whether such missing data are not collected or not made accessible. Most models with data managed to use at least one spatialized dataset (15/25, 60%) or time-series (23/25, 92%, Table C in S1 Text). This indicates that mechanistic models can resort to all types of data to try and compensate for the lack of precision in epidemiological reporting. Five studies used epidemiological data not published elsewhere [67,71,77,78,91], showing that modeling studies can also be seen as a way to valorize new datasets.

We categorized data use into three categories: calibration, input, and model assessment. Calibration was defined as the parametrization of one process or initial condition of the model, transforming the data in some way. This was done in 17 cases (Table C in S1 Text). Input was the fact of using the raw data directly as a parameter or initial condition of the model. This was done in 20 cases (Table C in S1 Text). Model assessment referred either to parameter inference or qualitative estimation looking to maximize similarity between epidemiological model outputs and data. This was done in 12 cases (Table C in S1 Text).

Ultimately, building accurate models helpful for policy makers requires the support of data. However, for RVF as well as for other infectious diseases, no single data source can be expected to inform each relevant parameter. Hence, the integration of information from many heterogeneous sources of data has become the norm [134]. This is a challenging task, as different datasets will be of different quality, potentially dependent, or in conflict [134]. Model-driven data collection can be a solution, but remains the exception rather than the rule [135]. Finally, we noted that in 40% of cases (4/10), models tailored to a location with known RVFV circulation, and which used epidemiological data, did not include any scientist from a local institution in their author list. This is important to develop more realistic and useful models, and at a time when concerns are being raised about the equity of South-North research collaborations [26,136,137].

Host and vector compartments

Most models (34/49) included a single vertebrate host category, most of the time broadly labeled as livestock without making distinction between species (25/34, Table 1). When two hosts were accounted for, it was most often done to add a human compartment (9/14, Table 1). Cecilia et al. (2020), Durand et al. (2020), Fischer et al. (2013), and Gachohi et al. (2016)[88,91,92,99] distinguished small ruminants (sheep and goats) from cattle. This grouping was made to incorporate differences in attractiveness to mosquitoes [88,91,92,99] or in RVF-induced mortality [88,91,99]. In addition to livestock, Barker et al. (2013) [73] included birds as incompetent hosts, used as alternate blood-feeding sources by vectors, namely Cx. tarsalis and Ae. melanimon. The model by McMahon et al. (2014) [95] was the only one explicitly including a wildlife compartment, but did not describe the way the associated carrying capacity, (i.e., the maximum population size which can be sustained by the environment) was estimated based on land use data. Sumaye et al. (2019) [94] included a probability to pick up infection from wildlife hosts with a single parameter. Beechler et al. (2015) and Manore & Beechler (2015) [66,67] both modeled African buffaloes (Syncerus caffer), either captive or free-ranging.

The role of wildlife seemed largely understudied. Even if RVFV circulation has been highlighted in several wildlife species, with clinical signs in some ruminants, the potential role of those species in the epidemiological sylvatic cycles in endemic areas is still poorly understood [138140]. Studying the competence of local wildlife species for RVFV transmission, along with their attractiveness to mosquitoes, is a prerequisite to determine the relevance of this question in a given territory [139,141143].

In hosts, assumptions regarding the clinical expression of the disease varied. Chitnis et al. (2013), McMahon et al. (2014), Pedro et al. (2014), and Pedro et al. (2016) [69,75,95,107] included an asymptomatic state in hosts. Durand et al. (2020), Gachohi et al. (2016), Leedale et al. (2016), Taylor et al. (2016), and Tennant et al. (2021) [8082,91,99] distributed hosts in age classes and (except Tennant et al. (2021) [80]) took into account differences in disease-induced mortality across classes. In Tennant et al. (2021) [80], only younger age classes moved between islands of the Comoros archipelago, and the initial proportion of immune individuals differed between classes. Cavalerie et al. (2015), Chamchod et al. (2014), Chamchod et al. (2016), Durand et al. (2020), and Sumaye et al. (2019) [71,91,94,100,108] incorporated abortion in livestock hosts due to RVFV infection.

In terms of transmission routes, Cavalerie et al. (2015), Durand et al. (2020) and Nicolas et al. (2014) [71,90,91] included the possibility of direct transmission between vertebrate hosts. Among eleven models including a human compartment (Table 1), nine considered livestock-to-human transmission by direct route (without vector) and ten models considered mosquito-to-human transmission. From these ten models, three [72,94,103] considered human-to-mosquito transmission. The low representation of this transmission route may reflect a confusion in the likely small role played by humans in the RVFV epidemiological cycle. As human-mosquito transmission has not been documented so far, humans may often be mistakenly considered as dead-end hosts [20,144]. Nevertheless, some data, while scarce, suggest they could develop a high viremia [144147], which would be sufficient to infect mosquitoes. Under this hypothesis, humans could have a role in the long distance spread of the virus [148]. Considering this knowledge gap and the difficulty to obtain direct observations on that matter, it would seem relevant for future models to evaluate whether human-to-mosquito transmission is necessary to explain observed transmission dynamics.

Models with explicit vector compartments (43/49) included one (n = 20), two (n = 20), or more (n = 3) vector taxa (Table 1). Models with two taxa were all combining Aedes and Culex spp. vectors, while models with one vector taxon often did not specify the genus or species (10/20). The diversity of vectors was important among studies considering them at the species level, with the most often represented in models being Ae. vexans (n = 5), followed by Cx. poicilipes (n = 4). Pedro et al. (2017) [106] studied ticks (Hyalomma truncatum) in addition to Aedes and Culex. Sumaye et al. (2019) [94] included Ae. mcintoshi, Ae. aegypti, and two generic Culex vectors in their model, distributed in different ecological zones of Tanzania. Cecilia et al. (2020) [88] included Ae. vexans, Cx. poicilipes, and Cx. tritaeniorhynchus distributed in different ecological zones of Senegal.

Eleven models (22%) incorporated the influence of abiotic factors on the life cycle and competence of vectors, with dedicated equations. Cecilia et al. (2020), EFSA AHAW Panel et al. (2020 –Model 2), Fischer et al. (2013), Leedale et al. (2016), Lo Iacono et al. (2018), and Mpeshe et al. (2014) [72,79—Model 2,82,88,92,93] took into account the influence of temperature and/or rainfall on the lifespan of adult vectors. Gachohi et al. (2016), Leedale et al. (2016), Lo Iacono et al. (2018), Mpeshe et al. (2014), Xue et al. (2012), and Xue et al. (2013) [72,74,76,82,93,99] took into account the influence of temperature and/or rainfall on the egg laying rate, and on the development or survival of aquatic stages. Barker et al. (2013), Cecilia et al. (2020), Fischer et al. (2013), Lo Iacono et al. (2018) Mpeshe et al. (2014), and EFSA AHAW Panel (2020—Model 2) [72,73,88,92,93] took into account the influence of temperature on the extrinsic incubation period (EIP) and on the biting rate. Durand et al. (2020) [91] considered it on EIP only and Leedale et al. (2016) [82] on biting rate only. Fischer et al. (2013), Lo Iacono et al. (2018), Mpeshe et al. (2014), and Durand et al. (2020) [72,9193] considered differences between Culex and Aedes mosquitoes for EIP and/or biting rate. Further sophistications, including the dependence to water body surface, were included into Cecilia et al. (2020), Durand et al. (2020), and in Lo Iacono et al. (2018) [88,91,93]. For Cecilia et al. (2020) and Durand et al. (2020) [88,91], this was done indirectly by relying on an external entomological model for vector population dynamics [149]. Overall, and due to the lack of data, modeling the impact of abiotic factors on the life cycle and competence of mosquitoes often relied on using data from different genera or species than those under study. In such cases, authors considered this choice preferable to a constant parameter or an arbitrary mathematical function.

Modelers are often faced with a substantial lack of data on vector presence and population dynamics when parameterizing their model. In Métras et al. (2017), Métras et al. (2020), and Tennant et al. (2021) [77,78,80], the lack of data on vector densities urged the authors to use an environmental proxy (Normalized Difference Vegetation Index (NDVI) or rainfall) to drive vectorial transmission, without including an explicit vector compartment. This type of data have been used previously to map RVFV transmission risk [150,151].

In reviewed models, the only source of variability in the feeding behavior of vectors was the inclusion of trophic preference for one host species over the others [88,91,92,99]. However, studies have suggested that the infected or uninfected status of the host might also play a role, for different pathogens [152,153], including for RVFV [154,155]. Future models could incorporate this mechanism to test its epidemiological importance.

Dealing with multiple hosts and vectors makes it difficult to predict disease emergence, spread, and potential for establishment. It has been shown that accounting for a higher biodiversity in epidemiological models can result in amplification or dilution effects depending on species’ competence and abundance [156,157]. In the case of RVFV, the role and contribution of hosts and vectors to transmission dynamics is largely understudied. Quantifying these roles is crucial to design targeted and efficient control strategies, and will require more knowledge on the intrinsic heterogeneity between host and vector species. Within-host and within-vector modeling can help in this matter, but such models for RVF are rare [97,158]. Besides, a paramount hypothesis driving model behavior is the contact structure assumed between hosts and vectors, mathematically embodied by the force of infection.

Force of infection

We chose to focus on the diversity of functional forms (FFs) used in RVF models for the force of infection related to vector-borne transmission. This was applied only to models explicitly including a vector compartment. Among those, a majority (29/43) did not justify their choice of FF, even though the force of infection, as a disease transmission term, encapsulates authors’ assumption on the host-vector interactions, and therefore influences their predictions (Fig 5, [159]).

Fig 5. Functional forms (FFs) used by models for their force of infection (FOI; vector-borne transmission only).

Fig 5

FR: reservoir frequency-dependent, FI: infectious frequency-dependent, MA: mass action; see section on Force of infection and Box 1 for details. The full bar length indicates the number of models using a given FF, the color determines how many models properly justified their choice of FF. See Eqs 16 for details on each FF. See Table 1 for details on papers using a given FF.

Six FFs were found in reviewed models (Table 1, Fig 5). We detail them in Box 1. Thirteen models used a reservoir frequency-dependent FF (Eq 1 in Box 1, Table 1, Fig 5). Eight models used a mass action FF (Eq 2 in Box 1, Table 1, Fig 5). Twelve models used an infectious frequency-dependent FF (Eq 3 in Box 1, Table 1, Fig 5). Ten models used alternative FFs, which all intended to avoid the shortcomings of other FFs by introducing parameters to constrain the contact rate between host and vector populations (Eqs 4–6 in Box. 1, called Hybrid1 (n = 8), Hybrid2 (n = 1), and Hybrid3 (n = 1) in Table 1 and Fig 5).

Box 1: Diversity of assumptions and functional forms for the force of infection in models of RVFV transmission dynamics

In standard susceptible-infected-recovered (SIR)-type models, the force of infection (FOI) is the rate at which individuals go from the susceptible (S) state to the infectious (I, or exposed, E) state. Biologically, the FOI can be decomposed as pcontact. pinf. ptransm. For vector-borne transmission, pcontact is the contact rate between vectors (subscript v) and hosts (subscript h), pinf is the probability that a given contact is with an infectious individual, and ptransm is the probability that a contact with an infectious individual results in successful transmission. This can be declined in two directions of transmission: vector-to-host and host-to-vector, which affects the value of these parameters. For pinf, under the hypothesis of homogeneous mixing, we have:

pinf,vh=IvNv
pinf,hv=IhNh

The value of ptransm can also vary depending on the source and target of the infection, but is not linked to host nor vector densities, but rather individual-level parameters (e.g., species, viremia, immune response). The different functional forms which can be seen in vector-borne disease models then arise from different assumptions on pcontact [160].

Reservoir frequency-dependence

The reservoir frequency-dependent (FR, n = 13, Eq 1) functional form assumes that the rate at which a vector bites hosts is constant across host (reservoir) densities (i.e., the vector does not feed more if there are more hosts), while the number of bites received by a host is proportional to the current vector-to-host ratio (i.e., a host is fed upon more if surrounded by more mosquitoes, at constant host population). Consequently, we get:

  • pcontact,hv = a, with a being the biting rate, usually defined as the maximal rate allowed by the gonotrophic cycle (i.e the minimum time required between blood meals for a female to produce and lay eggs). This results in FRhv=a.(IhNh).ptransm,hv.

  • pcontact,vh=a.NvNh which simplifies with pinf,vh and results in FRvh=a.(IvNh).ptransm,vh.

We can write, using βhv and βvh as aggregated terms, sometimes called adequate contact rates as in Gaff et al. (2007) [62]:

FRhv=βhv.IhNh
FRvh=βvh.IvNh (1)

This functional form (FF) is therefore called reservoir frequency-dependent because the total number of hosts is on the denominator for both transmission directions (vh and hv). With this FF, the vector-to-host transmission rate linearly increases with the vector-to-host ratio, and can therefore reach unrealistic values. Indeed, at some point, hosts are expected to deploy defense mechanisms to protect themselves from biting, preventing the vector population from getting all the blood meals needed.

Mass action

The mass action functional form (MA, n = 8, Eq 2), sometimes called pseudo mass action, is density-dependent. It assumes that a vector bites hosts at a rate proportional to the number of hosts, and that a host is bitten at a rate proportional to the number of vectors. Consequently, we get:

  • pcontact,hvNh, ignoring a possible constant derived from the previous biting rate a, which simplifies with pinf,hv and results in MAhvIh. ptransm,hv.

  • pcontact,vhNv, which similarly gives MAvhIv. ptransm,vh.

MAhv=βhv.Ih
MAvh=βvh.Iv (2)

With this functional form, the biting rate of vectors per unit time can exceed their physiological capacity above certain host densities, which again, becomes unrealistic.

Infected frequency-dependence

Following the nomenclature by Wonham et al. (2006) [159], who presented susceptible frequency dependence, we describe the infectious frequency-dependent (FI, n = 12, Eq 3) functional form. It assumes that the rate at which a vector bites hosts is constant across host (reservoir) densities, while the number of bites received by a host is constant across vector densities. The transmission terms are then both correlated to the proportion of infectious in the population:

FIhv=βhv.IhNh
FIvh=βvh.IvNv (3)

The only plausible situation inducing a constant contact rate in both directions is one where the vector-to-host ratio remains constant. Indeed, if we assume that a vector systematically gets the blood meals it physiologically needs, and modeled hosts are the sole source of blood, then a shortage in hosts (high vector-to-host ratio) should result in an increase in bites per host (FR functional form). Alternatively, if the number of bites received per host is saturated (and constant) to account for their defense mechanism, then a vector’s biting rate should vary with host densities, depending on whether this constrained system allows it to feed as it needs.

Alternative functional forms

Functional forms FR, MA, and FI can only apply biologically at certain population densities, outside of which they can generate aberrant values and therefore lead to erroneous predictions [159]. Three alternative FFs were found in RVF models to prevent this issue (Fig 5). Those FFs require additional parameters to constrain the contact rate between populations.

The first alternative FF (Eq 4, Hybrid1 in Table 1 and Fig 5, n = 8) was first used in a RVF model by Chitnis et al. (2013) [69], who previously formulated it in a model of malaria transmission [161].

Hyb1,hv=σvσhNhσvNv+σhNh.αvhIhNh
Hyb1,vh=σvσhNvσvNv+σhNh.αhvIvNv (4)

In Eq 4, αhv and αvh refer to probabilities of successful transmission given contact, from host to vector and vice versa. σv is defined as the maximum number of times a mosquito would bite a host per unit time, if freely available. This is a function of the mosquito’s gonotrophic cycle and its preference for a given host species. σh is the parameter added to avoid abnormally high contact rates and represents the maximum number of bites sustained by a host per unit time. Although σh seems virtually impossible to estimate in the field, this alternative FF can efficiently prevent erroneous model predictions and has therefore often been reused in RVF models. It is also the most justified FF (5/8, Fig 5). Some slight variations in its mathematical formulation can be found in Sumaye et al. (2019) [94].

The second alternative FF was used by McMahon et al. (2014) [95] (Eq 5, Hybrid2 in Table 1 and Fig 5, n = 1).

Hyb2,hv=infh.susv.era.Ih
Hyb2,vh=infv.sush.era.Iv
r=Nv+NhA (5)

Here, inf and sus refer to a vector or host infectivity and susceptibility, respectively. The contact rate is formulated as era, with a the characteristic length of local spread. In r, A is the patch area.

A last alternative FF was used in Lo Iacono et al. (2018) [93] (Eq 6, Hybrid3 in Table 1 and Fig 5, n = 1).

Hyb3,hv=αhv.θ˜IhNh
Hyb3,vh=αvh.m.θ˜IvNv
θ˜=θ1+mq
m=pf.NvNh (6)

Here, pf is the proportion of the mosquito population able to detect and feed on the host species under consideration, and m is therefore an ‘effective’ vector-to-host ratio. θ˜ is the biting rate, function of m, as well as of the rate of completion of the gonotrophic cycle θ, and of q, the vector-to-host ratio for which vector fecundity is divided by two. This is done to account for the decrease in fecundity in the case of absence of sufficient hosts to take a blood meal.

In 82% of cases (14/17), a model used the same FF for its force of infection as its parent model (Fig 2). In 9/14 cases, the parent model did not justify the choice of FF used, and no further justification was provided in the subsequent model in 7/9 cases. In 3/17 cases, the FF was changed compared to the parent model, which induced a justification in 2/3 cases. In addition, in three cases, the representation of vectors was implicit in a model and its parent model, therefore preventing the classification of the force of infection into any FF.

Several review papers on various epidemiological models concluded that the choice of a functional form for the force of infection could greatly affect model behavior. Begon et al. (2002), Hoch et al. (2018), and McCallum et al. (2001) [160,162,163] focused on non-vectorial transmission. Hopkins et al. (2020) [164] focused on parasite transmission, which could be through a vector, but did not include possible variations in frequency-dependent functions. Wonham et al. (2006) [159] focused on FFs used to model vectorial transmission of West Nile virus and also noticed an important diversity. In 2001, McCallum et al. were already recommending to "explicitly state and justify the form of transmission used" as well as "evaluate several alternative models of transmission, if possible" [163]. Contact structures between host and vector populations are hard to observe in natural conditions. This should be an additional incentive for modelers to explicitly state the reasoning behind their choice of functional form, which can be motivated by the context of their case study (e.g., expected host and vector densities, mixing between the populations). A comparison of the FF listed presently would be useful. The conclusions might vary depending on whether this is done through theoretical scenarios, keeping all other parameters equal, or by fitting different models to a common empirical dataset. The latter might not be able to discriminate between FF to select the best-performing one, because of underlying correlations between parameters.

Conclusion

In the last 5 years, more mechanistic models of RVFV transmission dynamics have been published (n = 26) than in the 10 previous years combined (n = 23). This possibly indicates a growing interest for RVF epidemiology, although it is known that the number of publications is continuously growing in all fields [26,165,166]. Our review highlighted important knowledge gaps, rarely addressed in mechanistic models of RVFV transmission dynamics. In our opinion, the most pressing issues are i) the incorporation of heterogeneity among host and vector species, in order to determine their relative role in transmission dynamics, which will require a focus at the within-host and within-vector scales, and ii) the development of large scale models, able to quantify the role of animal mobility in RVFV spread. Both of these research avenues will rely on novel data sets being generated, and will require methodological accuracy and transparency, particularly with regards to the choice of force of infection [113]. Indeed, as it reflects assumptions made on the contact rate between host and vector populations, this choice crucially influences model predictions and therefore cannot be made lightly. This systematic review showed that, as was the case for West Nile virus [159], models of RVFV transmission dynamics make very distinct assumptions which render their results not directly comparable. We detailed them didactically, hoping to guide future models focusing on vector-borne transmission.

This increasing number of models could also reflect a growing trust in mechanistic models in the field of infectious disease epidemiology [167,168]. When it comes to decision-making for disease management, we agree with previous work showing that combining models is the most sensible approach rather than attempting to find the best model [169,170]. Indeed, the diversity of models’ structure and hypotheses is a richness, which can be used to highlight actions that are robust to model uncertainty, but also identify key differences needing clarification through additional field exploration [169,170].

Importantly, we note that only seven studies made their code available (Table 1), which represents 23% of models published since 2015. Adopting this practice more broadly would increase the reproducibility of results and encourage the community to bring existing work further [110].

Supporting information

S1 Text. Reading grid and complementary tables.

Text A: Reading grid; Table A: Vaccination strategies implemented in models and main results; Table B: Characteristics of spatial models as well as non-spatial models with external renewal; Table C: Type of datasets and their use.

(DOCX)

Code used to produce figures and summary statistics is available in Github public repository at https://github.com/helenececilia/riftvalleyfever-model-review.git.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was part of the FORESEE project funded by INRAE metaprogram GISA (Integrated Management of Animal Health). HC was funded by INRAE, Région Pays de la Loire, CIRAD. We also would like to acknowledge the support of the French Ministry of Agriculture, which funded this research (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa. J Pathol Bacteriol. 1931;34(4):545–79. [Google Scholar]
  • 2.Chevalier V, de la Rocque S, Baldet T, Vial L, Roger F. Epidemiological processes involved in the emergence of vector-borne diseases: West Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever. Rev Sci Tech Int Off Epizoot. 2004. Aug;23(2):535–55. doi: 10.20506/rst.23.2.1505 [DOI] [PubMed] [Google Scholar]
  • 3.Birnberg L, Talavera S, Aranda C, Núñez AI, Napp S, Busquets N. Field-captured Aedes vexans (Meigen, 1830) is a competent vector for Rift Valley fever phlebovirus in Europe. Parasit Vectors. 2019. Oct 16;12(1):484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brustolin M, Talavera S, Nuñez A, Santamaría C, Rivas R, Pujol N, et al. Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus). Med Vet Entomol. 2017. Aug 7;31(4):365–72. [DOI] [PubMed] [Google Scholar]
  • 5.Lumley S, Hernández-Triana LM, Horton DL, Fernández de Marco MDM, Medlock JM, Hewson R, et al. Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus. Parasit Vectors. 2018. May 18;11(308):308:1–308:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB. Potential vectors of Rift Valley fever virus in the Mediterranean region. Vector-Borne Zoonotic Dis. 2008. Dec;8(6):749–53. doi: 10.1089/vbz.2008.0009 [DOI] [PubMed] [Google Scholar]
  • 7.Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL, Hribar LJ, et al. Potential for North American mosquitoes to transmit Rift Valley fever virus. J Am Mosq Control Assoc. 2008. Dec;24(4):502–7. doi: 10.2987/08-5791.1 [DOI] [PubMed] [Google Scholar]
  • 8.Turell MJ, Wilson WC, Bennett KE. Potential for North American mosquitoes (Diptera: Culicidae) to transmit Rift Valley fever virus. J Med Entomol. 2010. Sep 1;47(5):884–9. doi: 10.1603/me10007 [DOI] [PubMed] [Google Scholar]
  • 9.Hartman DA, Bergren NA, Kondash T, Schlatmann W, Webb CT, Kading RC. Susceptibility and barriers to infection of Colorado mosquitoes with Rift Valley fever virus. PLoS Negl Trop Dis. 2021. Oct 25;15(10):e0009837. doi: 10.1371/journal.pntd.0009837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Iranpour M, Turell MJ, Lindsay LR. Potential for Canadian mosquitoes to transmit Rift Valley fever virus. J Am Mosq Control Assoc. 2011. Dec;27(4):363–9. doi: 10.2987/11-6169.1 [DOI] [PubMed] [Google Scholar]
  • 11.Chevalier V. Relevance of Rift Valley fever to public health in the European Union. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2013. Aug;19(8):705–8. doi: 10.1111/1469-0691.12163 [DOI] [PubMed] [Google Scholar]
  • 12.Linthicum KJ, Britch SC, Anyamba A. Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol. 2016;61:395–415. doi: 10.1146/annurev-ento-010715-023819 [DOI] [PubMed] [Google Scholar]
  • 13.Tantely LM, Boyer S, Fontenille D. A review of mosquitoes associated with Rift Valley fever virus in Madagascar. Am J Trop Med Hyg. 2015. Apr 1;92(4):722–9. doi: 10.4269/ajtmh.14-0421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lumley S, Horton DL, Hernandez-Triana LLM, Johnson N, Fooks AR, Hewson R. Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes. J Gen Virol. 2017. May;98(5):875–87. doi: 10.1099/jgv.0.000765 [DOI] [PubMed] [Google Scholar]
  • 15.Davies FG. The historical and recent impact of Rift Valley fever in Africa. Am J Trop Med Hyg. 2010. Aug 5;83(Suppl 2):73–4. doi: 10.4269/ajtmh.2010.83s2a02 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rich KM, Wanyoike F. An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am J Trop Med Hyg. 2010. Aug 5;83(Suppl 2):52–7. doi: 10.4269/ajtmh.2010.09-0291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chevalier V, Pépin M, Plée L, Lancelot R. Rift Valley fever—a threat for Europe? Eurosurveillance. 2010. Mar 11;15(10):19506. [PubMed] [Google Scholar]
  • 18.Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis. 2003. Oct 15;37(8):1084–92. doi: 10.1086/378747 [DOI] [PubMed] [Google Scholar]
  • 19.Bird BH, Ksiazek TG, Nichol ST, MacLachlan NJ. Rift Valley fever virus. J Am Vet Med Assoc. 2009. Apr 1;234(7):883–93. doi: 10.2460/javma.234.7.883 [DOI] [PubMed] [Google Scholar]
  • 20.Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Depner K, Drewe JA, et al. Rift Valley fever—epidemiological update and risk of introduction into Europe. EFSA J. 2020;18(3):e06041. doi: 10.2903/j.efsa.2020.6041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Peyre M, Chevalier V, Abdo-Salem S, Velthuis A, Antoine-Moussiaux N, Thiry E, et al. A systematic scoping study of the socio-economic impact of Rift Valley fever: research gaps and needs. Zoonoses Public Health. 2015;62(5):309–25. doi: 10.1111/zph.12153 [DOI] [PubMed] [Google Scholar]
  • 22.Sindato C, Karimuribo E, Mboera LEG. The epidemiology and socio-economic impact of Rift Valley fever epidemics in Tanzania: a review. Tanzan J Health Res. 2011. Dec;13(5 Suppl 1):305–18. doi: 10.4314/thrb.v13i5.1 [DOI] [PubMed] [Google Scholar]
  • 23.FAO. Pastoralism in Africa’s drylands. Rome; 2018. 52 p. (Licence: CC BY-NC-SA 3.0 IGO.).
  • 24.Bron GM, Strimbu K, Cecilia H, Lerch A, Moore SM, Tran Q, et al. Over 100 years of Rift Valley fever: a patchwork of data on pathogen spread and spillover. Pathogens. 2021. Jun 5;10(6):708. doi: 10.3390/pathogens10060708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Clark MHA, Warimwe GM, Nardo AD, Lyons NA, Gubbins S. Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016. PLoS Negl Trop Dis. 2018. Jul 23;12(7):e0006627. doi: 10.1371/journal.pntd.0006627 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Cavalerie L, Wardeh M, Lebrasseur O, Nanyingi M, McIntyre KM, Kaba M, et al. One hundred years of zoonoses research in the Horn of Africa: A scoping review. PLoS Negl Trop Dis. 2021. Jul 16;15(7):e0009607. doi: 10.1371/journal.pntd.0009607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Martens WJM, Jetten TH, Rotmans J, Niessen LW. Climate change and vector-borne diseases. A global modelling perspective. Glob Environ Change Hum Policy Dimens. 1995;5:195–209. [Google Scholar]
  • 28.Colizza V, Barrat A, Barthélemy M, Vespignani A. Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study. BMC Med. 2007. Nov 21;5(1):34. doi: 10.1186/1741-7015-5-34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Endo A, van Leeuwen E, Baguelin M. Introduction to particle Markov-chain Monte Carlo for disease dynamics modellers. Epidemics. 2019. Dec 1;29:100363. doi: 10.1016/j.epidem.2019.100363 [DOI] [PubMed] [Google Scholar]
  • 30.Hartig F, Calabrese JM, Reineking B, Wiegand T, Huth A. Statistical inference for stochastic simulation models–theory and application. Ecol Lett. 2011;14(8):816–27. doi: 10.1111/j.1461-0248.2011.01640.x [DOI] [PubMed] [Google Scholar]
  • 31.Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol. 2008. Sep 7;254(1):178–96. doi: 10.1016/j.jtbi.2008.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Handel A, La Gruta NL, Thomas PG. Simulation modelling for immunologists. Nat Rev Immunol. 2020. Mar;20(3):186–95. doi: 10.1038/s41577-019-0235-3 [DOI] [PubMed] [Google Scholar]
  • 33.Cabral JS, Valente L, Hartig F. Mechanistic simulation models in macroecology and biogeography: state-of-art and prospects. Ecography. 2017;40(2):267–80. [Google Scholar]
  • 34.Radchuk V, Kramer-Schadt S, Grimm V. Transferability of mechanistic ecological models is about emergence. Trends Ecol Evol. 2019. Jun 1;34(6):487–8. doi: 10.1016/j.tree.2019.01.010 [DOI] [PubMed] [Google Scholar]
  • 35.Lessler J, Azman AS, Grabowski MK, Salje H, Rodriguez-Barraquer I. Trends in the mechanistic and dynamic modeling of infectious diseases. Curr Epidemiol Rep. 2016. Sep 1;3(3):212–22. doi: 10.1007/s40471-016-0078-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Métras R, Collins LM, White RG, Alonso S, Chevalier V, Thuranira-McKeever C, et al. Rift Valley fever epidemiology, surveillance, and control: what have models contributed? Vector-Borne Zoonotic Dis. 2011. Jun;11(6):761–71. doi: 10.1089/vbz.2010.0200 [DOI] [PubMed] [Google Scholar]
  • 37.Danzetta ML, Bruno R, Sauro F, Savini L, Calistri P. Rift Valley fever transmission dynamics described by compartmental models. Prev Vet Med. 2016. Nov;134:197–210. [DOI] [PubMed] [Google Scholar]
  • 38.Reiner RC, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, et al. A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010. J R Soc Interface. 2013. Apr 6;10(81):20120921. doi: 10.1098/rsif.2012.0921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. Mar 29;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021. Mar 29;372:n160. doi: 10.1136/bmj.n160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kimani T, Schelling E, Bett B, Ngigi M, Randolph T, Fuhrimann S. Public health benefits from livestock Rift Valley fever control: a simulation of two epidemics in Kenya. EcoHealth. 2016;13(4):729–42. doi: 10.1007/s10393-016-1192-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Favier C, Chalvet-Monfray K, Sabatier P, Lancelot R, Fontenille D, Dubois MA. Rift Valley fever in West Africa: the role of space in endemicity. Trop Med Int Health TM IH. 2006. Dec;11(12):1878–88. doi: 10.1111/j.1365-3156.2006.01746.x [DOI] [PubMed] [Google Scholar]
  • 43.Mweya CN, Holst N, Mboera LEG, Kimera SI. Simulation modelling of population dynamics of mosquito vectors for Rift Valley fever virus in a disease epidemic setting. PLoS ONE. 2014. Sep 26;9(9):e108430. doi: 10.1371/journal.pone.0108430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Fister KR, McCarthy ML, Oppenheimer SF. Diffusing wild type and sterile mosquitoes in an optimal control setting. Math Biosci. 2018;302:100–15. doi: 10.1016/j.mbs.2018.05.015 [DOI] [PubMed] [Google Scholar]
  • 45.Hammami P, Tran A, Kemp A, Tshikae P, Kgori P, Chevalier V, et al. Rift Valley fever vector diversity and impact of meteorological and environmental factors on Culex pipiens dynamics in the Okavango Delta, Botswana. Parasit Vectors. 2016. Aug 8;9(1):434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shocket MS, Verwillow AB, Numazu MG, Slamani H, Cohen JM, El Moustaid F, et al. Transmission of West Nile and five other temperate mosquito-borne viruses peaks at temperatures between 23°C and 26°C. eLife. 2020. 15;9. doi: 10.7554/eLife.58511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Manore CA, Hickmann KS, Hyman JM, Foppa IM, Davis JK, Wesson DM, et al. A network-patch methodology for adapting agent-based models for directly transmitted disease to mosquito-borne disease. J Biol Dyn. 2015. Jan;9(1):52–72. doi: 10.1080/17513758.2015.1005698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Konrad SK, Miller SN. A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America. Geospatial Health. 2012. May;6(2):161–70. doi: 10.4081/gh.2012.134 [DOI] [PubMed] [Google Scholar]
  • 49.Williams R, Malherbe J, Weepener H, Majiwa P, Swanepoel R. Anomalous high rainfall and soil saturation as combined risk indicator of Rift Valley fever outbreaks, South Africa, 2008–2011. Emerg Infect Dis. 2016. Dec;22(12):2054–62. doi: 10.3201/eid2212.151352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bouba F, Bah A, Cambier C, Ndiaye S, Ndione JA, Teisseire M. Decision making environment on Rift Valley fever in Ferlo (Senegal). Acta Biotheor. 2014. Sep;62(3):405–15. doi: 10.1007/s10441-014-9235-7 [DOI] [PubMed] [Google Scholar]
  • 51.Wielgus E, Caron A, Bennitt E, De Garine-Wichatitsky M, Cain B, Fritz H, et al. Inter-group social behavior, contact patterns and risk for pathogen transmission in Cape buffalo populations. J Wildl Manag. 2021;85(8):1574–90. [Google Scholar]
  • 52.Walsh MG, Mor SM. Interspecific network centrality, host range and early-life development are associated with wildlife hosts of Rift Valley fever virus. Transbound Emerg Dis. 2018. Dec;65(6):1568–75. doi: 10.1111/tbed.12903 [DOI] [PubMed] [Google Scholar]
  • 53.Golnar AJ, Kading RC, Hamer GL. Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States. Transbound Emerg Dis. 2018. Feb;65(1):85–95. doi: 10.1111/tbed.12608 [DOI] [PubMed] [Google Scholar]
  • 54.Marechal F, Ribeiro N, Lafaye M, Güell A. Satellite imaging and vector-borne diseases: the approach of the French National Space Agency (CNES). Geospatial Health. 2008. Nov;3(1):1–5. doi: 10.4081/gh.2008.226 [DOI] [PubMed] [Google Scholar]
  • 55.Kim Y, Métras R, Dommergues L, Youssouffi C, Combo S, Godais GL, et al. The role of livestock movements in the spread of Rift Valley fever virus in animals and humans in Mayotte, 2018–19. PLoS Negl Trop Dis. 2021. Mar 8;15(3):e0009202. doi: 10.1371/journal.pntd.0009202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Simons RRL, Croft S, Rees E, Tearne O, Arnold ME, Johnson N. Using species distribution models to predict potential hot-spots for Rift Valley fever establishment in the United Kingdom. PLoS ONE. 2019;14(12):e0225250. doi: 10.1371/journal.pone.0225250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Buczak AL, Babin SM, Feighner BH, Koshute PT, Lewis SH. Predictive modeling of emerging infections. In: Viral Infections and Global Change. 2013. p. 233–54. [Google Scholar]
  • 58.Anyamba A, Linthicum KJ, Small J, Britch SC, Tucker CJ. Remote sensing contributions to prediction and risk assessment of natural disasters caused by large-scale Rift Valley fever outbreaks. Proc IEEE. 2012;100(10):2824–34. [Google Scholar]
  • 59.Lafaye M, Sall B, Ndiaye Y, Vignolles C, Tourre YM, Borchi FO, et al. Rift Valley fever dynamics in Senegal: a project for pro-active adaptation and improvement of livestock raising management. Geospatial Health. 2013. Nov;8(1):279–88. [DOI] [PubMed] [Google Scholar]
  • 60.Bolzoni L, Pugliese A, Rosà R. The role of heterogeneity on the invasion probability of mosquito-borne diseases in multi-host models. J Theor Biol. 2015. Jul 21;377:25–35. doi: 10.1016/j.jtbi.2015.03.027 [DOI] [PubMed] [Google Scholar]
  • 61.Gulbudak H, Cannataro VL, Tuncer N, Martcheva M. Vector-borne pathogen and host evolution in a structured immuno-epidemiological system. Bull Math Biol. 2017. Feb;79(2):325–55. doi: 10.1007/s11538-016-0239-0 [DOI] [PubMed] [Google Scholar]
  • 62.Gaff H, Hartley DM, Leahy NP. An epidemiological model of Rift Valley fever. Electron J Differ Equ EJDEelectronic Only. 2007;2007:12. [Google Scholar]
  • 63.Gaff H, Burgess C, Jackson J, Niu T, Papelis Y, Hartley D. Mathematical model to assess the relative effectiveness of Rift Valley fever countermeasures. Int J Artif Life Res. 2011. Apr;2(2):1–18. [Google Scholar]
  • 64.Adongo D, Fister KR, Gaff H, Hartley D. Optimal control applied to Rift Valley fever. Nat Resour Model. 2013. Aug 1;26(3):385–402. [Google Scholar]
  • 65.Niu T, Gaff HD, Papelis YE, Hartley DM. An epidemiological model of Rift Valley fever with spatial dynamics. An GC, editor. Comput Math Methods Med. 2012. Aug 13;2012:138757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Manore CA, Beechler BR. Inter-epidemic and between-season persistence of Rift Valley fever: vertical transmission or cryptic cycling? Transbound Emerg Dis. 2015. Feb;62(1):13–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Beechler BR, Manore CA, Reininghaus B, O’Neal D, Gorsich EE, Ezenwa VO, et al. Enemies and turncoats: bovine tuberculosis exposes pathogenic potential of Rift Valley fever virus in a common host, African buffalo (Syncerus caffer). Proc R Soc B Biol Sci. 2015. Apr 22;282(1805):20142942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Mpeshe SC, Haario H, Tchuenche JM. A mathematical model of Rift Valley fever with human host. Acta Biotheor. 2011. Dec;59(3–4):231–50. doi: 10.1007/s10441-011-9132-2 [DOI] [PubMed] [Google Scholar]
  • 69.Chitnis N, Hyman JM, Manore CA. Modelling vertical transmission in vector-borne diseases with applications to Rift Valley fever. J Biol Dyn. 2013. Dec;7(1):11–40. doi: 10.1080/17513758.2012.733427 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Miron RE, Giordano GA, Kealey AD, Smith RJ. Multiseason transmission for Rift Valley fever in North America. Math Popul Stud. 2016;23(2):71–94. [Google Scholar]
  • 71.Cavalerie L, Charron MVP, Ezanno P, Dommergues L, Zumbo B, Cardinale E. A stochastic model to study Rift Valley fever persistence with different seasonal patterns of vector abundance: new insights on the endemicity in the tropical island of Mayotte. PLoS ONE. 2015. Jul 6;10(7):e0130838. doi: 10.1371/journal.pone.0130838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Mpeshe SC, Luboobi LS, Nkansah-Gyekye Y. Modeling the impact of climate change on the dynamics of Rift Valley fever. Comput Math Methods Med. 2014;2014:627586. doi: 10.1155/2014/627586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Barker CM, Niu T, Reisen WK, Hartley DM. Data-driven modeling to assess receptivity for Rift Valley fever virus. PLoS Negl Trop Dis. 2013. Nov 14;7(11):e2515. doi: 10.1371/journal.pntd.0002515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Xue L, Scott HM, Cohnstaedt LW, Scoglio C. A network-based meta-population approach to model Rift Valley fever epidemics. J Theor Biol. 2012. Aug;306:129–44. doi: 10.1016/j.jtbi.2012.04.029 [DOI] [PubMed] [Google Scholar]
  • 75.Pedro SA, Tonnang HEZ, Abelman S. Uncertainty and sensitivity analysis of a Rift Valley fever model. Appl Math Comput. 2016. Apr;279:170–86. [Google Scholar]
  • 76.Xue L, Cohnstaedt LW, Scott HM, Scoglio C. A hierarchical network approach for modeling Rift Valley fever epidemics with applications in North America. PLoS ONE. 2013. May 7;8(5):e62049. doi: 10.1371/journal.pone.0062049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Métras R, Edmunds WJ, Youssouffi C, Dommergues L, Fournié G, Camacho A, et al. Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018–2019 epidemic. Proc Natl Acad Sci U S A. 2020. 29;117(39):24567–74. doi: 10.1073/pnas.2004468117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Métras R, Fournié G, Dommergues L, Camacho A, Cavalerie L, Mérot P, et al. Drivers for Rift Valley fever emergence in Mayotte: a Bayesian modelling approach. PLoS Negl Trop Dis. 2017. Jul 21;11(7):e0005767. doi: 10.1371/journal.pntd.0005767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.EFSA AHAW Panel, Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Depner K, et al. Rift Valley fever–assessment of effectiveness of surveillance and control measures in the EU. EFSA J. 2020;18(11):e06292. doi: 10.2903/j.efsa.2020.6292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Tennant WSD, Cardinale E, Cêtre-Sossah C, Moutroifi Y, Le Godais G, Colombi D, et al. Modelling the persistence and control of Rift Valley fever virus in a spatially heterogeneous landscape. Nat Commun. 2021. Sep 22;12(1):5593. doi: 10.1038/s41467-021-25833-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Taylor D, Hagenlocher M, Jones AE, Kienberger S, Leedale J, Morse AP. Environmental change and Rift Valley fever in eastern Africa: projecting beyond HEALTHY FUTURES. Geospatial Health. 2016. Mar 31;11(1 Suppl):387. doi: 10.4081/gh.2016.387 [DOI] [PubMed] [Google Scholar]
  • 82.Leedale J, Jones AE, Caminade C, Morse AP. A dynamic, climate-driven model of Rift Valley fever. Geospatial Health. 2016. Mar 31;11(1 Suppl):394. doi: 10.4081/gh.2016.394 [DOI] [PubMed] [Google Scholar]
  • 83.Xiao Y, Beier JC, Cantrell RS, Cosner C, DeAngelis DL, Ruan S. Modelling the effects of seasonality and socioeconomic impact on the transmission of Rift Valley fever virus. PLoS Negl Trop Dis. 2015. Jan 8;9(1):e3388. doi: 10.1371/journal.pntd.0003388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Gao D, Cosner C, Cantrell RS, Beier JC, Ruan S. Modeling the spatial spread of Rift Valley fever in Egypt. Bull Math Biol. 2013. Mar 1;75(3):523–42. doi: 10.1007/s11538-013-9818-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Bicout DJ, Sabatier P. Mapping Rift Valley fever vectors and prevalence using rainfall variations. Vector-Borne Zoonotic Dis. 2004;4(1):33–42. doi: 10.1089/153036604773082979 [DOI] [PubMed] [Google Scholar]
  • 86.Scoglio CM, Bosca C, Riad MH, Sahneh FD, Britch SC, Cohnstaedt LW, et al. Biologically informed individual-based network model for Rift Valley fever in the US and evaluation of mitigation strategies. PLoS ONE. 2016. Sep 23;11(9):e0162759. doi: 10.1371/journal.pone.0162759 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Sekamatte M, Riad MH, Tekleghiorghis T, Linthicum KJ, Britch SC, Richt JA, et al. Individual-based network model for Rift Valley fever in Kabale District, Uganda. PLoS ONE. 2019. Mar 5;14(3):e0202721. doi: 10.1371/journal.pone.0202721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Cecilia H, Métras R, Fall AG, Lo MM, Lancelot R, Ezanno P. It’s risky to wander in September: Modelling the epidemic potential of Rift Valley fever in a Sahelian setting. Epidemics. 2020. Dec 1;33:2020.02.25.20027821. [DOI] [PubMed] [Google Scholar]
  • 89.Python Ndekou Tandong P, Ndiaye PI, Bah A, Dione D, Ndione JA. Coupling an agent-based model with a mathematical model of Rift Valley fever for studying the Impact of animal migrations on the Rift Valley fever transmission. In: Gervasi O, Murgante B, Misra S, Garau C, Blečić I, Taniar D, et al., editors. Computational Science and Its Applications–ICCSA 2020 . Cham: Springer International Publishing; 2020. p. 471–85. [Google Scholar]
  • 90.Nicolas G, Chevalier V, Tantely LM, Fontenille D, Durand B. A spatially explicit metapopulation model and cattle trade analysis suggests key determinants for the recurrent circulation of Rift Valley fever virus in a pilot area of Madagascar highlands. PLoS Negl Trop Dis. 2014. Dec 4;8(12):e3346. doi: 10.1371/journal.pntd.0003346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Durand B, Lo Modou M, Tran A, Ba A, Sow B, Belkhiria J, et al. Rift Valley fever in northern Senegal: a modelling approach to analyse the processes underlying virus circulation recurrence. PLoS Negl Trop Dis. 2020. Jun 1;14(6). doi: 10.1371/journal.pntd.0008009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Fischer EAJ, Boender GJ, Nodelijk G, de Koeijer AA, van Roermund HJW. The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study. Vet Res. 2013. Jul 22;44:58. doi: 10.1186/1297-9716-44-58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Lo Iacono G, Cunningham AA, Bett B, Grace D, Redding DW, Wood JLN. Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models. Proc Natl Acad Sci U S A. 2018. 31;115(31):E7448–56. doi: 10.1073/pnas.1803264115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Sumaye R, Jansen F, Berkvens D, De Baets B, Geubels E, Thiry E, et al. Rift Valley fever: An open-source transmission dynamics simulation model. PLoS ONE. 2019. Jan 9;14(1):e0209929. doi: 10.1371/journal.pone.0209929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.McMahon BH, Manore CA, Hyman JM, LaBute MX, Fair JM. Coupling vector-host dynamics with weather geography and mitigation measures to model Rift Valley fever in Africa. Math Model Nat Phenom. 2014;9(2):161–77. doi: 10.1051/mmnp/20149211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Gil H, Qualls WA, Cosner C, DeAngelis DL, Hassan A, Gad AM, et al. A model for the coupling of the Greater Bairam and local environmental factors in promoting Rift Valley fever epizootics in Egypt. Public Health. 2016. Jan 1;130:64–71. doi: 10.1016/j.puhe.2015.07.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Tuncer N, Gulbudak H, Cannataro VL, Martcheva M. Structural and practical identifiability issues of immuno-epidemiological vector–host models with application to Rift Valley fever. Bull Math Biol. 2016. Sep;78(9):1796–827. doi: 10.1007/s11538-016-0200-2 [DOI] [PubMed] [Google Scholar]
  • 98.Pedro SA, Abelman S, Tonnang HEZ. Predicting Rift Valley fever inter-epidemic activities and outbreak patterns: insights from a stochastic host-vector model. PLoS Negl Trop Dis. 2016. Dec 21;10(12):e0005167. doi: 10.1371/journal.pntd.0005167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Gachohi JM, Njenga MK, Kitala P, Bett B. Modelling vaccination strategies against Rift Valley fever in livestock in Kenya. PLoS Negl Trop Dis. 2016;10(12):e0005049. doi: 10.1371/journal.pntd.0005049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Chamchod F, Cantrell RS, Cosner C, Hassan AN, Beier JC, Ruan S. A modeling approach to investigate epizootic outbreaks and enzootic maintenance of Rift Valley fever virus. Bull Math Biol. 2014. Aug;76(8):2052–72. doi: 10.1007/s11538-014-9998-7 [DOI] [PubMed] [Google Scholar]
  • 101.Pedro SA. Basic properties and qualitative dynamics of a vector-borne disease model with vector stages and vertical transmission. J Appl Math. 2018. Nov 1;2018:1–16. [Google Scholar]
  • 102.Wen B, Teng Z, Liu W. Threshold dynamics in a periodic three-patch Rift Valley fever virus transmission model. Complexity. 2019. Jan 9;2019:1–18. [Google Scholar]
  • 103.Mpeshe SC. Fractional-order derivative model of Rift Valley fever in urban peridomestic cycle. Discrete Dyn Nat Soc. 2021. May 28;2021:e2941961. [Google Scholar]
  • 104.Xue L, Scoglio C. Network-level reproduction number and extinction threshold for vector-borne diseases. Math Biosci Eng. 2015;12(3):565–84. doi: 10.3934/mbe.2015.12.565 [DOI] [PubMed] [Google Scholar]
  • 105.Xue L, Scoglio C. The network level reproduction number for infectious diseases with both vertical and horizontal transmission. Math Biosci. 2013. May 1;243(1):67–80. doi: 10.1016/j.mbs.2013.02.004 [DOI] [PubMed] [Google Scholar]
  • 106.Pedro SA, Abelman S, Tonnang HEZ. The role of Hyalomma truncatum on the dynamics of Rift Valley fever: insights from a mathematical epidemic model. Acta Biotheor. 2017. Mar;65(1):1–36. [DOI] [PubMed] [Google Scholar]
  • 107.Pedro SA, Abelman S, Ndjomatchoua FT, Sang R, Tonnang HEZ. Stability, bifurcation and chaos analysis of vector-borne disease model with application to Rift Valley fever. PLoS ONE. 2014;9(10):e108172. doi: 10.1371/journal.pone.0108172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Chamchod F, Cosner C, Cantrell RS, Beier JC, Ruan S. Transmission dynamics of Rift Valley fever virus: effects of live and killed vaccines on epizootic outbreaks and enzootic maintenance. Front Microbiol. 2016;6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Yang CX, Nie LF. Modelling the use of impulsive vaccination to control Rift Valley fever virus transmission. Adv Differ Equ. 2016. May 18;2016(1):134. [Google Scholar]
  • 110.Boden LA, McKendrick IJ. Model-based policymaking: a framework to promote ethical “good practice” in mathematical modeling for public health policymaking. Front Public Health. 2017;5:68. doi: 10.3389/fpubh.2017.00068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Boender GJ, de Koeijer AA, Fischer E a. J. Derivation of a Floquet formalism within a natural framework. Acta Biotheor. 2012. Sep;60(3):303–17. doi: 10.1007/s10441-012-9162-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Bergren NA, Borland EM, Hartman DA, Kading RC. Laboratory demonstration of the vertical transmission of Rift Valley fever virus by Culex tarsalis mosquitoes. PLoS Negl Trop Dis. 2021. Mar 22;15(3):e0009273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Romoser WS, Oviedo MN, Lerdthusnee K, Patrican LA, Turell MJ, Dohm DJ, et al. Rift Valley fever virus-infected mosquito ova and associated pathology: possible implications for endemic maintenance. Res Rep Trop Med. 2011. Sep 19;2:121–7. doi: 10.2147/RRTM.S13947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Linthicum KJ, Davies FG, Kairo A, Bailey CL. Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. J Hyg (Lond). 1985;95(1):197–209. doi: 10.1017/s0022172400062434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Turell MJ, Hardy JL, Reeves WC. Stabilized infection of California encephalitis virus in Aedes dorsalis, and its implications for viral maintenance in nature. Am J Trop Med Hyg. 1982. Nov 1;31(6):1252–9. [DOI] [PubMed] [Google Scholar]
  • 116.Linthicum K, Logan T, Bailey C, Dohm D, Moulton J. Transstadial and horizontal transmission of Rift Valley fever virus in Hyalomma truncatum. Am J Trop Med Hyg. 1989. Nov 1;41:491–6. [DOI] [PubMed] [Google Scholar]
  • 117.Dohm DJ, Rowton ED, Lawyer PG, O’Guinn M, Turell MJ. Laboratory transmission of Rift Valley fever virus by Phlebotomus duboscqi, Phlebotomus papatasi, Phlebotomus sergenti, and Sergentomyia schwetzi (Diptera: Psychodidae). J Med Entomol. 2000. May 1;37(3):435–8. [DOI] [PubMed] [Google Scholar]
  • 118.Turell MJ, Perkins PV. Transmission of Rift Valley fever virus by the sand fly, Phlebotomus duboscqi (Diptera: Psychodidae). Am J Trop Med Hyg. 1990. Feb 1;42(2):185–8. [DOI] [PubMed] [Google Scholar]
  • 119.Hoch AL, Gargan TP, Bailey CL. Mechanical transmission of Rift Valley fever virus by hematophagous diptera. Am J Trop Med Hyg. 1985. Jan 1;34(1):188–93. doi: 10.4269/ajtmh.1985.34.188 [DOI] [PubMed] [Google Scholar]
  • 120.Anyamba A, Chretien JP, Small J, Tucker CJ, Formenty PB, Richardson JH, et al. Prediction of a Rift Valley fever outbreak. Proc Natl Acad Sci U S A. 2009. Jan 20;106(3):955–9. doi: 10.1073/pnas.0806490106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Anyamba A, Linthicum KJ, Small JL, Collins KM, Tucker CJ, Pak EW, et al. Climate teleconnections and recent patterns of human and animal disease outbreaks. PLoS Negl Trop Dis. 2012. Jan 24;6(1):e1465. doi: 10.1371/journal.pntd.0001465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Caminade C, Ndione JA, Kebe CMF, Jones AE, Danuor S, Tay S, et al. Mapping Rift Valley fever and malaria risk over West Africa using climatic indicators. Atmospheric Sci Lett. 2011;12(1):96–103. [Google Scholar]
  • 123.Caminade C, Ndione JA, Diallo M, MacLeod DA, Faye O, Ba Y, et al. Rift Valley fever outbreaks in Mauritania and related environmental conditions. Int J Environ Res Public Health. 2014. Jan;11(1):903–18. doi: 10.3390/ijerph110100903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Cianci D, Hartemink N, Ibáñez-Justicia A. Modelling the potential spatial distribution of mosquito species using three different techniques. Int J Health Geogr. 2015. Feb 27;14(1):10. doi: 10.1186/s12942-015-0001-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, et al. Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg. 2015. Jun 1;109(6):366–78. doi: 10.1093/trstmh/trv024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Sindato C, Stevens KB, Karimuribo ED, Mboera LEG, Paweska JT, Pfeiffer DU. Spatial heterogeneity of habitat suitability for Rift Valley fever occurrence in Tanzania: an ecological niche modelling approach. PLoS Negl Trop Dis. 2016. Sep 21;10(9):e0005002. doi: 10.1371/journal.pntd.0005002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Bartlow AW, Manore C, Xu C, Kaufeld KA, Del Valle S, Ziemann A, et al. Forecasting zoonotic infectious disease response to climate change: mosquito vectors and a changing environment. Vet Sci. 2019. May 6;6(2). doi: 10.3390/vetsci6020040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Campbell-Lendrum D, Manga L, Bagayoko M, Sommerfeld J. Climate change and vector-borne diseases: what are the implications for public health research and policy? Philos Trans R Soc B Biol Sci. 2015. Apr 5;370(1665):20130552. doi: 10.1098/rstb.2013.0552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Özkan Ş, Vitali A, Lacetera N, Amon B, Bannink A, Bartley DJ, et al. Challenges and priorities for modelling livestock health and pathogens in the context of climate change. Environ Res. 2016. Nov 1;151:130–44. doi: 10.1016/j.envres.2016.07.033 [DOI] [PubMed] [Google Scholar]
  • 130.Mansfield KL, Banyard AC, McElhinney L, Johnson N, Horton DL, Hernández-Triana LM, et al. Rift Valley fever virus: a review of diagnosis and vaccination, and implications for emergence in Europe. Vaccine. 2015. Oct 13;33(42):5520–31. doi: 10.1016/j.vaccine.2015.08.020 [DOI] [PubMed] [Google Scholar]
  • 131.Balkhy HH, Memish ZA. Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents. 2003. Feb 1;21(2):153–7. doi: 10.1016/s0924-8579(02)00295-9 [DOI] [PubMed] [Google Scholar]
  • 132.Napp S, Chevalier V, Busquets N, Calistri P, Casal J, Attia M, et al. Understanding the legal trade of cattle and camels and the derived risk of Rift Valley fever introduction into and transmission within Egypt. PLoS Negl Trop Dis. 2018. Jan 19;12(1):e0006143. doi: 10.1371/journal.pntd.0006143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Tigoi C, Sang R, Chepkorir E, Orindi B, Arum SO, Mulwa F, et al. High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: a cross-sectional survey in Kenya. PLoS Negl Trop Dis. 2020. Feb 21;14(2):e0007979. doi: 10.1371/journal.pntd.0007979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.De Angelis D, Presanis AM, Birrell PJ, Tomba GS, House T. Four key challenges in infectious disease modelling using data from multiple sources. Epidemics. 2015. Mar 1;10:83–7. doi: 10.1016/j.epidem.2014.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Lessler J, Edmunds WJ, Halloran ME, Hollingsworth TD, Lloyd AL. Seven challenges for model-driven data collection in experimental and observational studies. Epidemics. 2015. Mar 1;10:78–82. doi: 10.1016/j.epidem.2014.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Harvey B, Huang YS, Araujo J, Vincent K, Sabiiti G. Breaking vicious cycles? A systems perspective on Southern leadership in climate and development research programmes. Clim Dev. 2022. Jan 31;0(0):1–12. [Google Scholar]
  • 137.Sibai AM, Rizk A, Coutts AP, Monzer G, Daoud A, Sullivan R, et al. North–South inequities in research collaboration in humanitarian and conflict contexts. The Lancet. 2019. Nov 2;394(10209):1597–600. doi: 10.1016/S0140-6736(19)32482-1 [DOI] [PubMed] [Google Scholar]
  • 138.Bird BH, McElroy AK. Rift Valley fever virus: unanswered questions. Antiviral Res. 2016. Aug;132:274–80. doi: 10.1016/j.antiviral.2016.07.005 [DOI] [PubMed] [Google Scholar]
  • 139.Rostal MK, Liang JE, Zimmermann D, Bengis R, Paweska J, Karesh WB. Rift Valley fever: does wildlife play a role? ILAR J. 2017. Dec 15;58(3):359–70. doi: 10.1093/ilar/ilx023 [DOI] [PubMed] [Google Scholar]
  • 140.Britch SC, Binepal YS, Ruder MG, Kariithi HM, Linthicum KJ, Anyamba A, et al. Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya. PloS ONE. 2013;8(6):e66626. doi: 10.1371/journal.pone.0066626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Vuren PJV, et al. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect. 2008. Sep;136(9):1261–9. doi: 10.1017/S0950268807009806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Huyvaert KP, Russell RE, Patyk KA, Craft ME, Cross PC, Garner MG, et al. Challenges and opportunities developing mathematical models of shared pathogens of domestic and wild animals. Vet Sci. 2018. Dec;5(4):92. doi: 10.3390/vetsci5040092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Olive MM, Goodman SM, Reynes JM. The role of wild mammals in the maintenance of Rift Valley fever virus. J Wildl Dis. 2012. Apr;48(2):241–66. doi: 10.7589/0090-3558-48.2.241 [DOI] [PubMed] [Google Scholar]
  • 144.Rolin AI, Berrang-Ford L, Kulkarni MA. The risk of Rift Valley fever virus introduction and establishment in the United States and European Union. Emerg Microbes Infect. 2013. Jan 1;2(1):1–8. doi: 10.1038/emi.2013.81 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Njenga MK, Paweska J, Wanjala R, Rao CY, Weiner M, Omballa V, et al. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol. 2009. Apr;47(4):1166–71. doi: 10.1128/JCM.01905-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.de St Maurice A, Harmon J, Nyakarahuka L, Balinandi S, Tumusiime A, Kyondo J, et al. Rift Valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations. PLoS Negl Trop Dis. 2018. May 4;12(5):e0006460. doi: 10.1371/journal.pntd.0006460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Meegan JM. The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies. Trans R Soc Trop Med Hyg. 1979. Jan 1;73(6):618–23. [DOI] [PubMed] [Google Scholar]
  • 148.Gibson S, Linthicum KJ, Turell MJ, Anyamba A. Rift Valley fever virus: Movement of infected humans threatens global public health and agriculture. CABI Rev [Internet]. 2022. Aug 13 [cited 2022 Sep 28]; Available from: https://cabidigitallibrary.org/doi/ doi: 10.1079/cabireviews202217029 [DOI] [Google Scholar]
  • 149.Tran A, Fall AG, Biteye B, Ciss M, Gimonneau G, Castets M, et al. Spatial modeling of mosquito vectors for Rift Valley fever virus in Northern Senegal: integrating satellite-derived meteorological estimates in population dynamics models. Remote Sens. 2019. Apr 30;11(9):1024. [Google Scholar]
  • 150.Anyamba A, Linthicum KJ, Mahoney R, Tucker CJ, Kelley PW. Mapping potential risk of Rift Valley fever outbreaks in African savannas using vegetation index time series data. Photogramm Eng Remote Sens. 2002;68(2):137–45. [Google Scholar]
  • 151.Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science. 1999. Jul 16;285(5426):397–400. doi: 10.1126/science.285.5426.397 [DOI] [PubMed] [Google Scholar]
  • 152.Cozzarolo CS, Glaizot O, Christe P, Pigeault R. Enhanced attraction of arthropod vectors to infected vertebrates: a review of empirical evidence. Front Ecol Evol. 2020;8:568140. [Google Scholar]
  • 153.Zhang H, Zhu Y, Liu Z, Peng Y, Peng W, Tong L, et al. A volatile from the skin microbiota of flavivirus-infected hosts promotes mosquito attractiveness. Cell. 2022. Jul 7;185(14):2510–2522.e16. doi: 10.1016/j.cell.2022.05.016 [DOI] [PubMed] [Google Scholar]
  • 154.Turell MJ, Bailey CL, Rossi CA. Increased mosquito feeding on Rift Valley fever virus-infected lambs. Am J Trop Med Hyg. 1984. Nov 1;33(6):1232–8. doi: 10.4269/ajtmh.1984.33.1232 [DOI] [PubMed] [Google Scholar]
  • 155.Rossignol PA, Ribeiro JM, Jungery M, Turell MJ, Spielman A, Bailey CL. Enhanced mosquito blood-finding success on parasitemic hosts: evidence for vector-parasite mutualism. Proc Natl Acad Sci U S A. 1985. Nov;82(22):7725–7. doi: 10.1073/pnas.82.22.7725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Roberts MG, Heesterbeek J a. P. Quantifying the dilution effect for models in ecological epidemiology. J R Soc Interface. 2018. Mar 31;15(140):20170791. doi: 10.1098/rsif.2017.0791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Roche B, Guégan JF. Ecosystem dynamics, biological diversity and emerging infectious diseases. C R Biol. 2011. May 1;334(5):385–92. doi: 10.1016/j.crvi.2011.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Cecilia H, Vriens R, Schreur PJW, Wit MM de, Métras R, Ezanno P, et al. Heterogeneity of Rift Valley fever virus transmission potential across livestock hosts, quantified through a model-based analysis of host viral load and vector infection. PLoS Comput Biol. 2022. Jul 22;18(7):e1010314. doi: 10.1371/journal.pcbi.1010314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Wonham MJ, Lewis MA, Rencławowicz J, van den Driessche P. Transmission assumptions generate conflicting predictions in host-vector disease models: a case study in West Nile virus. Ecol Lett. 2006. Jun;9(6):706–25. doi: 10.1111/j.1461-0248.2006.00912.x [DOI] [PubMed] [Google Scholar]
  • 160.Begon M, Bennett M, Bowers RG, French NP, Hazel SM, Turner J. A clarification of transmission terms in host-microparasite models: numbers, densities and areas. Epidemiol Infect. 2002. Aug;129(1):147–53. doi: 10.1017/s0950268802007148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Chitnis N, Cushing JM, Hyman JM. Bifurcation analysis of a mathematical model for malaria transmission. SIAM J Appl Math. 2006. Jan;67(1):24–45. [Google Scholar]
  • 162.Hoch T, Touzeau S, Viet AF, Ezanno P. Between-group pathogen transmission: from processes to modeling. Ecol Model. 2018. Sep;383:138–49. [Google Scholar]
  • 163.McCallum H, Barlow N, Hone J. How should pathogen transmission be modelled? Trends Ecol Evol. 2001. Jun 1;16(6):295–300. doi: 10.1016/s0169-5347(01)02144-9 [DOI] [PubMed] [Google Scholar]
  • 164.Hopkins SR, Fleming-Davies AE, Belden LK, Wojdak JM. Systematic review of modelling assumptions and empirical evidence: does parasite transmission increase nonlinearly with host density? Methods Ecol Evol. 2020. Feb 25; [Google Scholar]
  • 165.Bornmann L, Mutz R. Growth rates of modern science: a bibliometric analysis based on the number of publications and cited references. J Assoc Inf Sci Technol. 2015;66(11):2215–22. [Google Scholar]
  • 166.Larsen PO, von Ins M. The rate of growth in scientific publication and the decline in coverage provided by Science Citation Index. Scientometrics. 2010. Sep 1;84(3):575–603. doi: 10.1007/s11192-010-0202-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, et al. Mathematical models: a key tool for outbreak response. Proc Natl Acad Sci. 2014. Dec 23;111(51):18095–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Ezanno P, Andraud M, Beaunée G, Hoch T, Krebs S, Rault A, et al. How mechanistic modelling supports decision making for the control of enzootic infectious diseases. Epidemics. 2020. Sep 1;32:100398. doi: 10.1016/j.epidem.2020.100398 [DOI] [PubMed] [Google Scholar]
  • 169.Webb CT, Ferrari M, Lindström T, Carpenter T, Dürr S, Garner G, et al. Ensemble modelling and structured decision-making to support emergency disease management. Prev Vet Med. 2017. Mar 1;138:124–33. doi: 10.1016/j.prevetmed.2017.01.003 [DOI] [PubMed] [Google Scholar]
  • 170.Probert WJM, Shea K, Fonnesbeck CJ, Runge MC, Carpenter TE, Dürr S, et al. Decision-making for foot-and-mouth disease control: Objectives matter. Epidemics. 2016. Jun 1;15:10–9. doi: 10.1016/j.epidem.2015.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010339.r001

Decision Letter 0

Michael J Turell, Robert C Reiner

19 May 2022

Dear Mr. Drouin,

Thank you very much for submitting your manuscript "Mechanistic models of Rift Valley fever virus transmission dynamics: A systematic review" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account my and the reviewers' comments.

General comment: I found this to be an interesting review of the various models of RVF, but as I am not a modeler, I was a little concerned as I could not tell which of the models cited were good and which were not, i.e., simply stating that “Eleven models (22%) incorporated the influence…” (line 496) doesn’t indicate how well these models did. One of the models incorporated ticks (see my comment 5 below) and I am not certain about many of the assumptions made on potential vectors. I also made a few minor editorial comments.

Specific comments:

1. Line 44: Yes, RVFV is primarily associated with Aedes and Culex mosquitoes, but numerous species of other mosquito genera have been found to be naturally infected in the field and shown to be competent vectors of RVFV in the laboratory. Depending on the situation, these species may play a critical role.

2. Line 58: All of the papers cited deal with European mosquitoes, but the sentence also says, “North America.” Why not also include “Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL Jr, Hribar LJ, et al. Potential for North American mosquitoes (Diptera: Culicidae) to transmit Rift Valley fever virus. J Am Mosq Control Assoc. 2008;24:502-7?”

3. Line 276: What do you mean by a vertical transmission rate of 10%? I assume that you mean than 10% of the orally infected mosquitoes produced at least 1 infected progeny and not that 10% of the progeny of the infected mosquitoes were infected. Given that vertical transmission is very rare to the first ovarian cycle progeny, and most of the infected mosquitoes won’t survive to produce a second cycle, how are you calculating this? What about stabilized infections, i.e., where in a very small percent of the mosquitoes, virtually 100% of their progeny, including first ovarian cycle progeny, are infected, and this persists for many, many generations. This is likely what allows RVFV to remain enzootic in a particular region.

4. Line 277: Why now use “transovarial” instead of vertical transmission. Yes, transovarial is likely to be the most important route of vertical transmission, but there is also transovum transmission. I would only use “vertical transmission.”

5. Line 295: Yes, Pedro et al. (2017) looked at what might happen if ticks could transmit RVFV. However, the last sentence of their abstract is, “These findings suggest that if ticks are capable of transmitting the virus, they may be contributing to disease outbreaks and endemicity.” Has anyone ever shown that an orally exposed tick, of any species, is able to transmit RVFV? If not, then why not include mites, lice, and various biting flies?

6. Line 336-338: Here the authors are stating that if “even with R0 < 1, RVF was likely to become endemic when live vaccines were implemented.” Do they mean that if a killed vaccine was used that RVF would NOT become enzootic? Note, as RVF is primarily a disease of animals, then shouldn’t it be enzootic, rather than endemic?

7. Line 340: Yes, everyone refers to larval developmental sites as “breeding” sites, but “breeding” has a sexual connotation, and mosquitoes do not “breed” in these locations. It would be more accurate to refer to them as “larval developmental sites.”

8. Line 355-357: Was it the “movement restriction between Grande Comore and other islands of the archipelago led to a more severe and delayed outbreak” or were other factors also involved that actually caused the more severe outbreak?

9. Lines 453-454: Yes, “livestock” does appear to be a single vertebrate host, but what if the area had cattle, goats, and sheep? These would all be considered livestock, but a certainly not a single vertebrate host.

10. Lines 458-459: Yes, as incompetent vertebrate hosts, birds might interfere with RVFV transmission. However, many of the mosquitoes, particularly the Aedes, that are involved in RVFV transmission preferentially feed on mammals. Therefore, whether birds were present or not would make little difference. This is unlike the situation with cattle as an alternative host for Anopheles mosquitoes and malaria, where the presence of cattle near a home may provide an attractive alternative host that was incompetent for human malaria and thus reduces malaria in the area.

11. Line 486: Why would humans be a dead-end host? Viremias in humans are extremely high, often more than 8 logs, i.e., higher than often observed in adult cattle, goats, or sheep. This is unlike viruses such as West Nile virus and Japanese encephalitis virus in which humans produce such a low viremia that they are indeed dean-end hosts.

12. Line 491: Why would Ae. vexans be the most common in these models? The very few studies on the ability of Ae. vexans orally exposed to RVFV to transmit RVFV indicate that there is a very wide range in vector competence for this species, ranging from <1% in the northern U.S., 5% in Europe, to about 20% in the southeastern U.S. I know of no studies that have determined if African strains of Ae. vexans are competent vectors. Note, isolation of virus from a field-collected mosquito does NOT mean that it is capable of transmitting that virus. Various arboviruses, including RVFV, have been detected in mosquito species that have been shown to be incompetent and thus not vectors.

13. Lines 504-506: yes, these models may have taken this into account, but the effect differs for different vectors, so how did they do that?

14. Lines 539-589: This is not as simple as it appears. For example, if 1 in 50 of the sheep in a flock is infected, most models would assume that 1 in 50 mosquitoes feeding on an animal in that flock would be exposed to virus. That is not correct. RVFV-infected animals are more attractive to a blood-seeking mosquito than their uninfected siblings, so greater than 1 in 50 would have been exposed to virus. Similarly, many mosquitoes may be dislodged before they obtain a blood meal, but mosquitoes are able to obtain a blood meal more rapidly from a RVFV-infected animal than from an uninfected member of the same species. Again, the successful feeding rate on RVFV-infected animals would be higher than the percent of animals actually infected. Have either of these been incorporated in the models?

15. References: Please ensure that all references are formatted correctly.

a. In manuscript titles, only the first word and all proper nouns should be capitalized. See references 1, 14 and others where “rift valley fever.” should have been “Rift Valley fever.” See also references 7, 8, 10, and others where each word is capitalized, even if not a proper noun. Please check all of the references.

b. See references 41 and 46. Is it PLOS ONE or PLoS ONE?

c. What does the “Larchmt N” mean in reference 54?

d. Why do you list the editor for some of the PLoS journals?

e. Please go through all of the references and ensure that they are properly formatted.

Minor comments:

16. Line 44: Both “Aedes” and “Culex” should be in italics.

17. Line 91: RVFV was established non line 57 and should be used here. See also lines 278, 290, 376, 466 etc.

18. Line 151, Figure 1: The first block indicates that 372 records were identified (236 + 136). The next block indicates that 123 of these were removed prior to screening. So why weren’t 249, instead of 248 screened? In all of the other reductions, the numbers do match?

19. Line 169: Shouldn’t “4 cases…” be “four cases…” See also lines 367, 391-394, 421, etc. I am fine with using a numeral within a parentheses, but you need to be consistent outside of a parentheses.

20. Line 342: Is it really necessary, or even accurate, to present lifetime to a hundredth of a day? Why not simply state, “under 8.7 days…”

21. Line 448: Why is 4/10 39% instead of 40%?

22. Line 480: Is it RVF infection or RVFV infection? This occurs throughout the manuscript. Mosquitoes do not transmit RVF, they transmit the virus that causes RVF.

23. Lines 499-500: Shouldn’t “on the lifespan of adult vectors lifespan” be “on the lifespan of adult vectors?”

24. Line 530: What is a SIR-type model? I assume that the authors are referring to a susceptible-infected-recovered model, but don’t know if the reader will get that. Also, in Table 1, is it “sensible” or “susceptible?” I think that susceptible is more accurate.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Michael J Turell, Ph.D.

Associate Editor

PLOS Neglected Tropical Diseases

Robert Reiner

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

General comment: I found this to be an interesting review of the various models of RVF, but as I am not a modeler, I was a little concerned as I could not tell which of the models cited were good and which were not, i.e., simply stating that “Eleven models (22%) incorporated the influence…” (line 496) doesn’t indicate how well these models did. One of the models incorporated ticks (see my comment 5 below) and I am not certain about many of the assumptions made on potential vectors. I also made a few minor editorial comments.

Specific comments:

1. Line 44: Yes, RVFV is primarily associated with Aedes and Culex mosquitoes, but numerous species of other mosquito genera have been found to be naturally infected in the field and shown to be competent vectors of RVFV in the laboratory. Depending on the situation, these species may play a critical role.

2. Line 58: All of the papers cited deal with European mosquitoes, but the sentence also says, “North America.” Why not also include “Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL Jr, Hribar LJ, et al. Potential for North American mosquitoes (Diptera: Culicidae) to transmit Rift Valley fever virus. J Am Mosq Control Assoc. 2008;24:502-7?”

3. Line 276: What do you mean by a vertical transmission rate of 10%? I assume that you mean than 10% of the orally infected mosquitoes produced at least 1 infected progeny and not that 10% of the progeny of the infected mosquitoes were infected. Given that vertical transmission is very rare to the first ovarian cycle progeny, and most of the infected mosquitoes won’t survive to produce a second cycle, how are you calculating this? What about stabilized infections, i.e., where in a very small percent of the mosquitoes, virtually 100% of their progeny, including first ovarian cycle progeny, are infected, and this persists for many, many generations. This is likely what allows RVFV to remain enzootic in a particular region.

4. Line 277: Why now use “transovarial” instead of vertical transmission. Yes, transovarial is likely to be the most important route of vertical transmission, but there is also transovum transmission. I would only use “vertical transmission.”

5. Line 295: Yes, Pedro et al. (2017) looked at what might happen if ticks could transmit RVFV. However, the last sentence of their abstract is, “These findings suggest that if ticks are capable of transmitting the virus, they may be contributing to disease outbreaks and endemicity.” Has anyone ever shown that an orally exposed tick, of any species, is able to transmit RVFV? If not, then why not include mites, lice, and various biting flies?

6. Line 336-338: Here the authors are stating that if “even with R0 < 1, RVF was likely to become endemic when live vaccines were implemented.” Do they mean that if a killed vaccine was used that RVF would NOT become enzootic? Note, as RVF is primarily a disease of animals, then shouldn’t it be enzootic, rather than endemic?

7. Line 340: Yes, everyone refers to larval developmental sites as “breeding” sites, but “breeding” has a sexual connotation, and mosquitoes do not “breed” in these locations. It would be more accurate to refer to them as “larval developmental sites.”

8. Line 355-357: Was it the “movement restriction between Grande Comore and other islands of the archipelago led to a more severe and delayed outbreak” or were other factors also involved that actually caused the more severe outbreak?

9. Lines 453-454: Yes, “livestock” does appear to be a single vertebrate host, but what if the area had cattle, goats, and sheep? These would all be considered livestock, but a certainly not a single vertebrate host.

10. Lines 458-459: Yes, as incompetent vertebrate hosts, birds might interfere with RVFV transmission. However, many of the mosquitoes, particularly the Aedes, that are involved in RVFV transmission preferentially feed on mammals. Therefore, whether birds were present or not would make little difference. This is unlike the situation with cattle as an alternative host for Anopheles mosquitoes and malaria, where the presence of cattle near a home may provide an attractive alternative host that was incompetent for human malaria and thus reduces malaria in the area.

11. Line 486: Why would humans be a dead-end host? Viremias in humans are extremely high, often more than 8 logs, i.e., higher than often observed in adult cattle, goats, or sheep. This is unlike viruses such as West Nile virus and Japanese encephalitis virus in which humans produce such a low viremia that they are indeed dean-end hosts.

12. Line 491: Why would Ae. vexans be the most common in these models? The very few studies on the ability of Ae. vexans orally exposed to RVFV to transmit RVFV indicate that there is a very wide range in vector competence for this species, ranging from <1% in the northern U.S., 5% in Europe, to about 20% in the southeastern U.S. I know of no studies that have determined if African strains of Ae. vexans are competent vectors. Note, isolation of virus from a field-collected mosquito does NOT mean that it is capable of transmitting that virus. Various arboviruses, including RVFV, have been detected in mosquito species that have been shown to be incompetent and thus not vectors.

13. Lines 504-506: yes, these models may have taken this into account, but the effect differs for different vectors, so how did they do that?

14. Lines 539-589: This is not as simple as it appears. For example, if 1 in 50 of the sheep in a flock is infected, most models would assume that 1 in 50 mosquitoes feeding on an animal in that flock would be exposed to virus. That is not correct. RVFV-infected animals are more attractive to a blood-seeking mosquito than their uninfected siblings, so greater than 1 in 50 would have been exposed to virus. Similarly, many mosquitoes may be dislodged before they obtain a blood meal, but mosquitoes are able to obtain a blood meal more rapidly from a RVFV-infected animal than from an uninfected member of the same species. Again, the successful feeding rate on RVFV-infected animals would be higher than the percent of animals actually infected. Have either of these been incorporated in the models?

15. References: Please ensure that all references are formatted correctly.

a. In manuscript titles, only the first word and all proper nouns should be capitalized. See references 1, 14 and others where “rift valley fever.” should have been “Rift Valley fever.” See also references 7, 8, 10, and others where each word is capitalized, even if not a proper noun. Please check all of the references.

b. See references 41 and 46. Is it PLOS ONE or PLoS ONE?

c. What does the “Larchmt N” mean in reference 54?

d. Why do you list the editor for some of the PLoS journals?

e. Please go through all of the references and ensure that they are properly formatted.

Minor comments:

16. Line 44: Both “Aedes” and “Culex” should be in italics.

17. Line 91: RVFV was established non line 57 and should be used here. See also lines 278, 290, 376, 466 etc.

18. Line 151, Figure 1: The first block indicates that 372 records were identified (236 + 136). The next block indicates that 123 of these were removed prior to screening. So why weren’t 249, instead of 248 screened? In all of the other reductions, the numbers do match?

19. Line 169: Shouldn’t “4 cases…” be “four cases…” See also lines 367, 391-394, 421, etc. I am fine with using a numeral within a parentheses, but you need to be consistent outside of a parentheses.

20. Line 342: Is it really necessary, or even accurate, to present lifetime to a hundredth of a day? Why not simply state, “under 8.7 days…”

21. Line 448: Why is 4/10 39% instead of 40%?

22. Line 480: Is it RVF infection or RVFV infection? This occurs throughout the manuscript. Mosquitoes do not transmit RVF, they transmit the virus that causes RVF.

23. Lines 499-500: Shouldn’t “on the lifespan of adult vectors lifespan” be “on the lifespan of adult vectors?”

24. Line 530: What is a SIR-type model? I assume that the authors are referring to a susceptible-infected-recovered model, but don’t know if the reader will get that. Also, in Table 1, is it “sensible” or “susceptible?” I think that susceptible is more accurate.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: N/A - review paper, not hypothesis driven

y

y (but n/a hypothesis)

y (but n/a hypothesis)

N/A

N

Reviewer #2: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? NA

-Is the study design appropriate to address the stated objectives? Yes

-Is the population clearly described and appropriate for the hypothesis being tested? NA

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? NA

-Were correct statistical analysis used to support conclusions? Yes

-Are there concerns about ethical or regulatory requirements being met? No

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: y

y - very well presented

y - figures are excellent graphical communication of results

Reviewer #2: -Does the analysis presented match the analysis plan? Yes

-Are the results clearly and completely presented? Yes

-Are the figures (Tables, Images) of sufficient quality for clarity? Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: y

y

y

y

Reviewer #2: -Are the conclusions supported by the data presented? Yes

-Are the limitations of analysis clearly described? Yes

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? Yes

-Is public health relevance addressed? NA

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Editorial recommendations:

- ms is very readable and accessible; authors do well bringing the reader into their view and objectives; good balance of technical and narrative content

- make sure each "e.g." and "i.e." is followed by a comma

- use serial commas (i.e., make sure there is a comma before the "and" or the "or" in a list of three or more items in text, such as line 118 or line 398)

- check that parenthetical statements are properly closed with a ")" ... e.g., in line 76. Overall, I would go through the whole ms to minimize use of parenthetical statements by rewording. However, the way you use them in for example lines 125-129 makes sense and works well.

- check for correct grammar with the word "data" which is a plural term - I think there was only one place (line 429) but check throughout

- be consistent with either numbering or using author/date in-text citations (e.g., in-text citations throughout the paragraph lines 365-376 are inconsistent with journal style)(on the other hand, the way you combine them in lines 159-171 makes sense and works well)

- check that "R" (as used in Ro, etc.) is italicized throughout

- lines 93-94: suggest rewording "To achieve this, we categorized models as either theoretical or applied, and explored these categories throughout the paper to identify what they have in common and how they differ."

- suggest find a way to make the count in line 31 and line 148 match (I understand it was 48 papers but 49 studies because one paper had two studies)

- lines 118-120: suggest rewording to "Records selected in the first and second step went to a full text screening of the corresponding report, using a combination of the first set of exclusion criteria along with these additional exclusion criteria:"

- line 238 should be four categories not five?

- lines 482-485: suggest rewording for clarity ... do you mean "Among 11 models including a human compartment (Table 1), three [42,64,73] considered human-to-mosquito transmission, 10 considered mosquito-to-human transmission, and one [67] considered livestock-to-human transmission."

Reviewer #2: Minor Revision

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: First I want to thank you for a very well written, timely, and informative paper.

This manuscript synthesizes 48 Rift Valley fever virus modeling papers (49 studies) using very creative methods of analysis and communication of findings.

The figures are very well executed and valuable, and greatly enhance the text descriptions and tabulated analysis.

The ‘reading grid’ structured analysis of the papers makes a lot of sense and is a very defendable method for bringing together input from multiple co-authors.

The objective of the study is to summarize a state-of-the-science which also includes a gap analysis to guide future research.

The methodical, stepwise discussion of how key features of mechanistic disease models are handled across the studies will be very useful not only to guide future project designs, but also is very instructive and accessible for early career modelers.

I have a few recommendations to improve the ms for publication:

Lines 75-76 … can you elaborate on why phenomenological should be used instead of statistical?

Lines 93-95 … should you mention the “gray” category here?

Lines 98-99 … Force of Infection section (lines 524-621) … this section is very useful and interesting but possibly could be in the SI? I only say this because the intro paragraph (525-529) could almost skip straight to the “results” paragraph (starting 628) where you bring the narrative back to the papers you analyzed. As a reader, it left me a little lost until I understood what you were doing with the 524-621 section (i.e., setting the basis for your analysis and comment). Moving 524-621 to SI could keep the reader focused on your findings. Also, given that you devoted so much to the FOI issue, I expected more exploration and impact of this topic in the Conclusions.

Lines 247-263 (and possibly other sections, such as line 448) … the tallies you provide for the number of studies that attain various criteria throughout this paragraph are not identifiable by the reader to the specific studies. This is in contrast to other such tallies elsewhere in the ms that reference for example the Tables where the reader can translate each tally into the specific studies. You do reference Fig 3 but I don’t see a way to get to the specific studies tallied in 247-263 via this figure. This could be resolved by an additional table in SI that accompanies Fig. 3. Or maybe the existing tables have the relevant info and just need to be referenced in text?

Line 387 … could you list the countries?

Line 423 … is spatialized the same as data that are organically spatial? Or does it mean the data were fitted by the modeler to a spatial context?

Line 428 … could you describe what the specific data gaps were in those cited studies?

Line 468 … could add “Britch SC, Binepal YS, Ruder MG, Kariithi HM, Linthicum KJ, Anyamba A, et al. Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya. PLoS One. 2013;8: e66626”

Line 480 … should be RVFV infection (not RVF infection)

Lines 485-487 … recommend citing Njenga et al. 2009 because humans can develop viremia sufficient to infect mosquitoes (Njenga MK, Paweska J, Wanjala R, Rao CY, Weiner M, Omballa V, et al. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol. 2009;47: 1166–1171). Also Rolin et al. 2013 is a good reference for the idea of humans as dead end hosts (Rolin AI, Berrang-Ford L, Kulkarni MA. The risk of Rift Valley fever virus introduction and establishment in the United States and European Union. Emerg Microbes Infect. 2013;2: e81). We have recently submitted a review paper on the risk of spread of RVFV via infected humans - unfortunately still in review but will share with you if you are interested.

Lines 512-513 … the NDVI basis for modeling RVFV risk was pioneered by Anyamba and Linthicum … I realize their models may have not met your criteria for inclusion in this ms but the NDVI technique for understanding RVFV transmission risk should be cited to them (Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science. 1999;285: 397–400; Anyamba A, Linthicum KJ, Mahoney R, Tucker CJ, Kelley PW. Mapping potential risk of Rift Valley fever outbreaks in African savannas using vegetation index time series data. Photogramm Eng Remote Sens. 2002;68: 137–145.) … in particular because the predictions of the Rift Valley Fever Monitor (https://www.ars.usda.gov/southeast-area/gainesville-fl/center-for-medical-agricultural-and-veterinary-entomology/docs/rvf_monthlyupdates/) guided mass vaccination and prevention of an epizootic (Linthicum KJ, Britch SC, Anyamba A. Rift Valley fever: An emerging mosquito-borne disease. Annu Rev Entomol. 2016;61: 395–415; Anyamba A, Chretien J-P, Britch SC, Soebiyanto RP, Small JL, Jepsen R, et al. Global Disease Outbreaks Associated with the 2015-2016 El Niño Event. Sci Rep. 2019;9: 1930.

Lines 659-660: yes absolutely … this is a very timely and operationally relevant conclusion and direction for future research. Movement (legal, illegal) of infected livestock among regions in RVFV endemic areas is becoming more and more important. Increasing instances of interepizootic transmission of RVFV to humans throughout the African continent and the Arabian Peninsula driven by movement of infected livestock (Eisa et al. 1980, Meegan and Bailey 1989, Balkhy and Memish 2003, LaBeaud et al. 2008, Mohamed et al. 2014, Napp et al. 2018, Tigoi et al. 2020) increase the risk of globalization of RVFV.

Balkhy HH, Memish ZA. Rift Valley fever: an uninvited zoonosis in the Arabian Peninsula. Int J Antimicrob Agents. 2003;21: 153–157.

Eisa M, Kheir el-Sid ED, Shomein AM, Meegan JM. An outbreak of Rift Valley fever in the Sudan - 1976. Trans R Soc Trop Med Hyg. 1980;74: 417–419.

LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, et al. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis. 2008;14: 1240–1246.

Meegan JM, Bailey CL. Rift Valley fever. In: Monath TP, editor. The Arboviruses. CRC Press, Inc., Boca Raton, FL; 1989. pp. 51–76.

Mohamed AM, Ashshi AM, Asghar AH, Abd El-Rahim IHA, El-Shemi AG, Zafar T. Seroepidemiological survey on Rift Valley fever among small ruminants and their close human contacts in Makkah, Saudi Arabia, in 2011. Rev Sci Tech. 2014;33: 903–915.

Napp S, Chevalier V, Busquets N, Calistri P, Casal J, Attia M, et al. Understanding the legal trade of cattle and camels and the derived risk of Rift Valley fever introduction into and transmission within Egypt. PLoS Negl Trop Dis. 2018;12: e0006143.

Tigoi C, Sang R, Chepkorir E, Orindi B, Arum SO, Mulwa F, et al. High risk for human exposure to Rift Valley fever virus in communities living along livestock movement routes: A cross-sectional survey in Kenya. PLoS Negl Trop Dis. 2020;14: e0007979.

Reviewer #2: The review is quite detailed. The gap in literature was pointed out. Below are some comments and suggestions,

1. Page 2, Line 4, the sentence `... go the extra miles' should be rephreased.'

2. Page 2, Line 43, remove `in'.

3. Page 3, Line 73, the sentence needs to be rephrased.

4. Page 3, Line 83, change `risk' into `risks'.

5. Page 4, Line 93, remove `models in'.

6. Page 6, Line 139, change `model' into `models'.

7. Page 21, Line 333, change `was' into `were'.

8. Page 22, Line 342, change R0 ito $R_0$.

9. Page 22, Line 354, add comma after `However'.

10.Page 23, Line 371, remove `between'.

11. Page 31, Page 32, add commas between the two equalities in equations (1), (2), and (3).

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Seth C. Britch

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010339.r003

Decision Letter 1

Michael J Turell, Robert C Reiner

16 Aug 2022

Dear Mr. Drouin,

Thank you very much for submitting a revised version of your manuscript "Mechanistic models of Rift Valley fever virus transmission dynamics: A systematic review" for consideration at PLOS Neglected Tropical Diseases. Based on the review, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to my and the reviewer’s recommendations.

Below are a few more comments that need to be addressed.

Specific Commenrts:

1. Line 59: Yes, RVFV has been detected in several Anopheles species, but are Anopheles competent vectors of RVFV. Just because a mosquito feeds on a viremic animal and ingests virus does not make it a vector. Anopheles tend to have an extreme salivary gland barrier for RVFV and are virtually unable to transmit this virus. While rarely tested for RVFV, various species of sand flies are competent vectors, and RVFV is a member of the genus of sand fly fever viruses.

2. Line 195, Table 1: What does “Vector health status” mean? Should that be “Vector infection status?”

3. Line 283: Much better, but is “unrealistic” sufficient? Remember, The Romoser paper detected evidence of RVFV in one egg in 8.6% of the RVFV-inoculated mosquitoes. Because they were inoculated, this rate would be much higher than in mosquitoes that had ingested RVFV. Also, given that each mosquito lays about 150 eggs/oviposition cycle, the 8.6% of females with an infected egg translates to 0.06% of the progeny of the RVFV-inoculated mosquitoes would be infected. If the model used 20%, then to me, the model is beyond unrealistic when the rate would be <0.1% of the progeny of RVFV-inoculated mosquitoes. However, as you now point out, if a mosquito had a stabilized infection with RVFV, that would change everything.

4. Lines 304-306: Yes, the importation of an infectious disease into an area where it is not currently present can allow for a major outbreak. Why is that surprising? If the Ro is > 1, then you will get an outbreak. For RVF, I believe that the Ro is strongly affected by the presence (and number) of competent vectors and the presence of competent vertebrate amplifying hosts (e.g., cattle, goats, sheep, and various wildlife).

5. Lines 308-312: The association between bovine tuberculosis and RVF is interesting. Just curious, does infection with RVF make a cow more susceptible to BTB, or are herds that are in certain locations more like to be infected with both agents (i.e., neither pathogen affects the replication of the other, but certain areas are more likely to have either both or neither of the two pathogens)? Yes, if your model incorporates increases the amount of RVF with increasing amounts of BTB, isn’t it obvious that it will predict more RVFV in a population with a higher BTB positivity?

6. Lines 312-317: Again, better, but why even include a paper about ticks? Because RVFV is a member of the genus Phlebovirus (i.e., sand fly fever virus) and various species of sand flies have been proven (in the laboratory) to be competent vectors of RVFV, why hasn’t someone included them in the model, or in the case of this manuscript, why isn’t it pointed out that these models are missing? To me, that is much more important than devoting space to a tick model.

7. Lines 363-363: How the use of larvicides, even in a low transmission context could increase RVF incidences seems contra intuitive to me. How did this model find this increase in incidence? Yes, during an outbreak, larvicides would be ineffective as they would not reduce the number of infected vectors present. However, the use of adulticides would reduce the vector population and be more effective. So, if you compared areas that used larvicides with those that used adulticides, then there might be more transmission in the areas that used larvicides. However, that is not what the manuscript implies.

8. Lines 379-383: Yes, I know that the model predicts that “stamping out in a 20km radius was the most effective strategy. However, given that this disease has never been observed in Europe, how accurate is that model? Would intensive mosquito control be critical. How many infectious cases in cattle would be subclinical and allow the virus to continue to spread? My concern is that given the lack of data going into these models, that a control practice based solely on this model may allow for RVFV to become enzootic.

9. Line 478: Yes, the models only applied to “livestock,” but is that really on a single vertebrate host species? Livestock consists of several species.

10. Line 512-516: Thanks for modifying this a little, but it illustrates a much bigger problem. Yes, many studies consider humans to be a dead-end host. This is probably because with nearly all of the other zoonotic arboviruses, i.e., eastern equine encephalitis virus, western equine encephalitis virus, Japanese encephalitis virus, etc., humans produce a very low viremia and are thus a dead-end host. Therefore, humans must be a dead end host for RVF too. However, studies indicate that the viremia in humans infected with RVFV can be extremely high, often >8 logs, i.e., higher than in adult cattle, goats, or sheep (see Meegan 1979, Trans R Soc Trop Med). Note that the de St. Maurice et al. 2017 paper cited (ref 139), only found viremias about 5-6 logs, but didn’t start testing until about 5 days after the onset of fever, by which time viremias would have fallen greatly. Yes, unfortunately, there are relatively few studies that have looked at viremias in humans, but even implying that humans are a dead-end host is misleading and dangerous. Given the number of humans that visit enzootic areas every year, if one of them became infected, given rapid transportation, they could easily transport RVFV back to an area (Europe or the Americas) where this virus is not yet present. Transportation of animals is important for local movement of RVF, but humans may be much more important for long range movement.

11. Lines 551-553: See also Rossignol PA, Ribeiro JM, Jungery M, Turell MJ, Spielman A, Bailey CL. Enhanced mosquito blood-finding success on parasitemic hosts: evidence for vector-parasite mutualism. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7725-7. That paper showed that mosquitoes were able to feed significantly more rapidly on a RVFV-infected animal as compared to an uninfected one and is one of the explanations for why mosquitoes are more successful in feeding on a RVFV-infected animal. Not mentioned here is that infected animals may have less “anti-mosquito” behavior because they are ill or that because they are febrile that they might be more “attractive” to a host-seeking mosquito.

Minor:

12. line 40: “modellers…” should be “modelers…”

13. Line 43: There should not be a “,” after “priorities” as the next phrase is not a complete sentence. Same comment on line 51 for the comma after “choices.”

14. Line 289 (and elsewhere): Is it “endemic” or “enzootic” circulation/areas?

15. Line 346: What do you mean by “both host populations?” Is it cattle and small ruminants or is it cattle and humans? Above the sentence seems to imply small ruminants, but the discussion below implies humans.

16. Line 394: Shouldn’t “Rift Valley fever virus transmission” be “RVFV transmission?

17. Line 452: Shouldn’t “exposure ; and” be “exposure; and” with no space before the colon?

18. Line 610: As “years” are a unit of measurement, it should be “5 years…” Similarly, on line 611, it should be “10 previous years…”

19. Line 640: Shouldn’t “Bibliography” be “References?”

20. References: Much better.

a. Line 735, reference 40: “Rift Valley Fever…” should be “Rift Valley fever…?” See also references 76, 93, 125 and possibly others.

b. Line 740, reference 42: Here, “Culex pipiens” is not in italics, but in the other references, species names have been in italics. Please be consistent.

c. Line 1014, reference 145: Only the first word and proper nouns in a title should be capitalized.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Michael J Turell, Ph.D.

Academic Editor

PLOS Neglected Tropical Diseases

Robert Reiner

Section Editor

PLOS Neglected Tropical Diseases

***********************

Thanks for the revised version and addressing many of the comments made by me and the reviewers. Below are a few more comments that need to be addressed.

Specific Commenrts:

1. Line 59: Yes, RVFV has been detected in several Anopheles species, but are Anopheles competent vectors of RVFV. Just because a mosquito feeds on a viremic animal and ingests virus does not make it a vector. Anopheles tend to have an extreme salivary gland barrier for RVFV and are virtually unable to transmit this virus. While rarely tested for RVFV, various species of sand flies are competent vectors, and RVFV is a member of the genus of sand fly fever viruses.

2. Line 195, Table 1: What does “Vector health status” mean? Should that be “Vector infection status?”

3. Line 283: Much better, but is “unrealistic” sufficient? Remember, The Romoser paper detected evidence of RVFV in one egg in 8.6% of the RVFV-inoculated mosquitoes. Because they were inoculated, this rate would be much higher than in mosquitoes that had ingested RVFV. Also, given that each mosquito lays about 150 eggs/oviposition cycle, the 8.6% of females with an infected egg translates to 0.06% of the progeny of the RVFV-inoculated mosquitoes would be infected. If the model used 20%, then to me, the model is beyond unrealistic when the rate would be <0.1% of the progeny of RVFV-inoculated mosquitoes. However, as you now point out, if a mosquito had a stabilized infection with RVFV, that would change everything.

4. Lines 304-306: Yes, the importation of an infectious disease into an area where it is not currently present can allow for a major outbreak. Why is that surprising? If the Ro is > 1, then you will get an outbreak. For RVF, I believe that the Ro is strongly affected by the presence (and number) of competent vectors and the presence of competent vertebrate amplifying hosts (e.g., cattle, goats, sheep, and various wildlife).

5. Lines 308-312: The association between bovine tuberculosis and RVF is interesting. Just curious, does infection with RVF make a cow more susceptible to BTB, or are herds that are in certain locations more like to be infected with both agents (i.e., neither pathogen affects the replication of the other, but certain areas are more likely to have either both or neither of the two pathogens)? Yes, if your model incorporates increases the amount of RVF with increasing amounts of BTB, isn’t it obvious that it will predict more RVFV in a population with a higher BTB positivity?

6. Lines 312-317: Again, better, but why even include a paper about ticks? Because RVFV is a member of the genus Phlebovirus (i.e., sand fly fever virus) and various species of sand flies have been proven (in the laboratory) to be competent vectors of RVFV, why hasn’t someone included them in the model, or in the case of this manuscript, why isn’t it pointed out that these models are missing? To me, that is much more important than devoting space to a tick model.

7. Lines 363-363: How the use of larvicides, even in a low transmission context could increase RVF incidences seems contra intuitive to me. How did this model find this increase in incidence? Yes, during an outbreak, larvicides would be ineffective as they would not reduce the number of infected vectors present. However, the use of adulticides would reduce the vector population and be more effective. So, if you compared areas that used larvicides with those that used adulticides, then there might be more transmission in the areas that used larvicides. However, that is not what the manuscript implies.

8. Lines 379-383: Yes, I know that the model predicts that “stamping out in a 20km radius was the most effective strategy. However, given that this disease has never been observed in Europe, how accurate is that model? Would intensive mosquito control be critical. How many infectious cases in cattle would be subclinical and allow the virus to continue to spread? My concern is that given the lack of data going into these models, that a control practice based solely on this model may allow for RVFV to become enzootic.

9. Line 478: Yes, the models only applied to “livestock,” but is that really on a single vertebrate host species? Livestock consists of several species.

10. Line 512-516: Thanks for modifying this a little, but it illustrates a much bigger problem. Yes, many studies consider humans to be a dead-end host. This is probably because with nearly all of the other zoonotic arboviruses, i.e., eastern equine encephalitis virus, western equine encephalitis virus, Japanese encephalitis virus, etc., humans produce a very low viremia and are thus a dead-end host. Therefore, humans must be a dead end host for RVF too. However, studies indicate that the viremia in humans infected with RVFV can be extremely high, often >8 logs, i.e., higher than in adult cattle, goats, or sheep (see Meegan 1979, Trans R Soc Trop Med). Note that the de St. Maurice et al. 2017 paper cited (ref 139), only found viremias about 5-6 logs, but didn’t start testing until about 5 days after the onset of fever, by which time viremias would have fallen greatly. Yes, unfortunately, there are relatively few studies that have looked at viremias in humans, but even implying that humans are a dead-end host is misleading and dangerous. Given the number of humans that visit enzootic areas every year, if one of them became infected, given rapid transportation, they could easily transport RVFV back to an area (Europe or the Americas) where this virus is not yet present. Transportation of animals is important for local movement of RVF, but humans may be much more important for long range movement.

11. Lines 551-553: See also Rossignol PA, Ribeiro JM, Jungery M, Turell MJ, Spielman A, Bailey CL. Enhanced mosquito blood-finding success on parasitemic hosts: evidence for vector-parasite mutualism. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7725-7. That paper showed that mosquitoes were able to feed significantly more rapidly on a RVFV-infected animal as compared to an uninfected one and is one of the explanations for why mosquitoes are more successful in feeding on a RVFV-infected animal. Not mentioned here is that infected animals may have less “anti-mosquito” behavior because they are ill or that because they are febrile that they might be more “attractive” to a host-seeking mosquito.

Minor:

12. line 40: “modellers…” should be “modelers…”

13. Line 43: There should not be a “,” after “priorities” as the next phrase is not a complete sentence. Same comment on line 51 for the comma after “choices.”

14. Line 289 (and elsewhere): Is it “endemic” or “enzootic” circulation/areas?

15. Line 346: What do you mean by “both host populations?” Is it cattle and small ruminants or is it cattle and humans? Above the sentence seems to imply small ruminants, but the discussion below implies humans.

16. Line 394: Shouldn’t “Rift Valley fever virus transmission” be “RVFV transmission?

17. Line 452: Shouldn’t “exposure ; and” be “exposure; and” with no space before the colon?

18. Line 610: As “years” are a unit of measurement, it should be “5 years…” Similarly, on line 611, it should be “10 previous years…”

19. Line 640: Shouldn’t “Bibliography” be “References?”

20. References: Much better.

a. Line 735, reference 40: “Rift Valley Fever…” should be “Rift Valley fever…?” See also references 76, 93, 125 and possibly others.

b. Line 740, reference 42: Here, “Culex pipiens” is not in italics, but in the other references, species names have been in italics. Please be consistent.

c. Line 1014, reference 145: Only the first word and proper nouns in a title should be capitalized.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #3: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #3: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #3: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #3: This study represents a valuable exercise in reviewing all modeling studies of RVFV using a systematic literature review. Although reviews of the RVFV system have occurred frequently, this study updates a synthesis of published models and provides an excellent framework for evaluating different aspects of past applied and theoretical models. The inclusion of inheritance connections among the studies is also a nice feature. I have a few minor observations to improve the manuscript.

Ln. 144. Could ‘and insights remain distant from field preoccupations’ be explained better as I don’t understand what that means.

Ln. 417-475. This is a great observation to point out. However, every author on this current systematic review appears to have an affiliation with an institution in France.

Ln. 518. This statement ‘while models with one taxon often did not precise the genus of vector studied’ could be changed to ‘while models with one vector taxon did not specify genus or species’ for clarity.

Figure 2 and 5. The legend nor text explain what ‘FR’, ‘FI’, mean in either of these figures. The Box explains but it would be helpful to at least include the name of the abbreviation to help interpret the figures.

Figure 4. For the ‘Location and number of RVF models.’. Does this ‘location’ refer to where the authors were from or where the model was parameterized in terms of geographic location? I assume it is the latter but it is hard to tell this in the methods or this Figure 4 legend so this could be clarified.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010339.r005

Decision Letter 2

Michael J Turell, Robert C Reiner

23 Sep 2022

Dear Mr. Drouin,

Thank you very much for submitting a revised version of your manuscript, "Mechanistic models of Rift Valley fever virus transmission: A systematic review" for consideration at PLOS Neglected Tropical Diseases. I appreciated the attention to an important topic. We are likely to accept this manuscript for publication, providing that you modify the manuscript according to the comments below.

Thanks for the revised version and addressing the comments made by me and the reviewer. My only real issue is stating that people consider humans to be a dead-end host for RVFV. Please see my comment 5 below as well as a few minor comments.

1. Line 33: Insert a space between “models” and “with”

2. Line 39: Insert a space after the period after “transmission” and shouldn’t this be in the past tense, so shouldn’t “we note a…” be “we noted a…?”

3. Line 193: Shouldn’t there be a “period” after “et al” instead of a “comma?”

4. Lines 370-372: Again, how could the use of larvicides increase the proportion of infected mosquitoes? Yes, the use of larvicides is generally ineffective in disease prevention. This is because it does not kill any of the infectious mosquitoes that are already out there. Was this only in their model, or is there any real-world evidence that the use of larvicides led to an increased evidence of disease.

5. Lines 519-523: Yes, there are a number of papers that have mentioned that humans are a dead-end host for RVFV. Note, if this paper is publish as currently written, it too will be cited as evidence that humans are a dead-end host for RVFV. They are not! Unfortunately, as humans are dead-end hosts for most zoonotic viruses (West Nile, eastern equine encephalitis, Japanese encephalitis, St. Louis encephalitis, etc.) some people assumed that humans must be a dead-end host of this zoonotic pathogen. In the very few studies that have looked at viremias in active human infections, viremias can be very high (actually higher than in cattle or sheep). That being said, humans probably play a very small role in the outbreak spread of RVFV because the reduced number of mosquito bites/day on a human compared to a cow. However, that small role is not due to them being a dead-end host, which implies that the viremia is too low to infect a mosquito. In fact, humans are probably the most likely way that RVFV will eventually spread to the Americas and Europe, i.e., in a tourist bitten by an infectious mosquito while visiting one of the enzootic areas to look at wildlife. I do not want this paper to be another one cited that humans are a dead-end host. How about, “…human-to-mosquito transmission. This is in line with humans not being considered important in the outbreak spread of RVFV because of limited mosquito biting of humans compared with livestock. However, some…”

6. Line 550: Should “genus” be “genera” as it could be more than one genus?

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Michael J Turell, Ph.D.

Academic Editor

PLOS Neglected Tropical Diseases

Robert Reiner

Section Editor

PLOS Neglected Tropical Diseases

***********************

Thanks for the revised version and addressing the comments made by me and the reviewer. My only real issue is stating that people consider humans to be a dead-end host for RVFV. Please see my comment 5 below as well as a few minor comments.

1. Line 33: Insert a space between “models” and “with”

2. Line 39: Insert a space after the period after “transmission” and shouldn’t this be in the past tense, so shouldn’t “we note a…” be “we noted a…?”

3. Line 193: Shouldn’t there be a “period” after “et al” instead of a “comma?”

4. Lines 370-372: Again, how could the use of larvicides increase the proportion of infected mosquitoes? Yes, the use of larvicides is generally ineffective in disease prevention. This is because it does not kill any of the infectious mosquitoes that are already out there. Was this only in their model, or is there any real-world evidence that the use of larvicides led to an increased evidence of disease.

5. Lines 519-523: Yes, there are a number of papers that have mentioned that humans are a dead-end host for RVFV. Note, if this paper is publish as currently written, it too will be cited as evidence that humans are a dead-end host for RVFV. They are not! Unfortunately, as humans are dead-end hosts for most zoonotic viruses (West Nile, eastern equine encephalitis, Japanese encephalitis, St. Louis encephalitis, etc.) some people assumed that humans must be a dead-end host of this zoonotic pathogen. In the very few studies that have looked at viremias in active human infections, viremias can be very high (actually higher than in cattle or sheep). That being said, humans probably play a very small role in the outbreak spread of RVFV because the reduced number of mosquito bites/day on a human compared to a cow. However, that small role is not due to them being a dead-end host, which implies that the viremia is too low to infect a mosquito. In fact, humans are probably the most likely way that RVFV will eventually spread to the Americas and Europe, i.e., in a tourist bitten by an infectious mosquito while visiting one of the enzootic areas to look at wildlife. I do not want this paper to be another one cited that humans are a dead-end host. How about, “…human-to-mosquito transmission. This is in line with humans not being considered important in the outbreak spread of RVFV because of limited mosquito biting of humans compared with livestock. However, some…”

6. Line 550: Should “genus” be “genera” as it could be more than one genus?

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010339.r007

Decision Letter 3

Michael J Turell, Robert C Reiner

31 Oct 2022

Dear Mr. Drouin,

Thank you for making the suggested changes and we are pleased to inform you that your manuscript 'Mechanistic models of Rift Valley fever virus transmission: A systematic review' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Michael J Turell, Ph.D.

Academic Editor

PLOS Neglected Tropical Diseases

Robert Reiner

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0010339.r008

Acceptance letter

Michael J Turell, Robert C Reiner

9 Nov 2022

Dear Dr. Durand,

We are delighted to inform you that your manuscript, "Mechanistic models of Rift Valley fever virus transmission: A systematic review," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Reading grid and complementary tables.

    Text A: Reading grid; Table A: Vaccination strategies implemented in models and main results; Table B: Characteristics of spatial models as well as non-spatial models with external renewal; Table C: Type of datasets and their use.

    (DOCX)

    Code used to produce figures and summary statistics is available in Github public repository at https://github.com/helenececilia/riftvalleyfever-model-review.git.

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers v2.docx

    Attachment

    Submitted filename: Response to reviewers v4.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES